Publications for David Celermajer

2021Baker, D., Celermajer, D. (2021). Acute aortic dissection as alate and fatal complication of transcatheter persistent ductusarteriosus occlusion: a case report. European Heart Journal -Case Reports, 5(1), ytaa484. <ahref="http://dx.doi.org/10.1093/ehjcr/ytaa484">[MoreInformation]</a>

Rehan, R., Kotchetkova, I., Cordina, R., Celermajer, D. (2021).Adult Congenital Heart Disease Survivors at Age 50 Years:Medical and Psychosocial Status. Heart, Lung, and Circulation,30(2), 261-266. <ahref="http://dx.doi.org/10.1016/j.hlc.2020.05.114">[MoreInformation]</a>

Cai, T., Mosalman Haghighi, M., Roberts, P., Mervis, J.,Qasem, A., Butlin, M., Celermajer, D., Avolio, A., Skilton, M.,Ayer, J. (2021). Assessment of Central Arterial Hemodynamicsin Children: Comparison of Noninvasive and InvasiveMeasurements. American Journal of Hypertension, 34(2), 163-171. <a href="http://dx.doi.org/10.1093/ajh/hpaa148">[MoreInformation]</a>

Khandkar, C., Madhavan, M., Weaver, J., Celermajer, D.,Karimi Galougahi, K. (2021). Atherothrombosis in AcuteCoronary Syndromes-From Mechanistic Insights to TargetedTherapies. Cells, 10(4). <ahref="http://dx.doi.org/10.3390/cells10040865">[MoreInformation]</a>

Lim, M., Celermajer, D., Bannon, P. (2021). Bicuspid aorticvalve disease � the influence of valve morphotype on age atand types of surgical treatment. IJC Heart & Vasculature, 34.<a href="http://dx.doi.org/10.1016/j.ijcha.2021.100786">[MoreInformation]</a>

Dissanayake, H., McMullan, R., Kong, Y., Caterson, I.,Celermajer, D., Phang, M., Raynes-Greenow, C., Polson, J.,Gordon, A., Skilton, M. (2021). Cardiac and vascular health inlate preterm infants (In Press). Journal of DevelopmentalOrigins of Health and Disease. <ahref="http://dx.doi.org/10.1017/S204017442100009X">[MoreInformation]</a>

Strange, G., Playford, D., Scalia, G., Celermajer, D., Prior, D.,Codde, J., Chan, Y., Bulsara, M., Stewart, S. (2021). Change inejection fraction and long-term mortality in adults referred forechocardiography. European Journal of Heart Failure, 23(4),555-563. <a href="http://dx.doi.org/10.1002/ejhf.2161">[MoreInformation]</a>

Lee, T., D'Souza, K., Hameed, A., Yao, J., Lam, S., Chadban,S., Ying, T., Celermajer, D., Sandroussi, C., Pleass, H., et al(2021). Comparison of the effect of single vs dual antiplateletagents on post-operative haemorrhage after renaltransplantation: A systematic review and meta-analysis.Transplantation Reviews, 35(1), 100594. <ahref="http://dx.doi.org/10.1016/j.trre.2020.100594">[MoreInformation]</a>

Playford, D., Strange, G., Celermajer, D., Evans, G., Scalia, G.,Stewart, S., Prior, D. (2021). Diastolic dysfunction andmortality in 436?360 men and women: the National EchoDatabase Australia (NEDA). European Heart Journal -Cardiovascular Imaging, 22(5), 505-515. <ahref="http://dx.doi.org/10.1093/ehjci/jeaa253">[MoreInformation]</a>

Koay, Y., Stanton, K., Kienzle, V., Li, M., Yang, J.,Celermajer, D., O'Sullivan, J. (2021). Effect of chronic exercisein healthy young male adults: a metabolomic analysis.Cardiovascular Research, 117(2), 613-622. <ahref="http://dx.doi.org/10.1093/cvr/cvaa051">[MoreInformation]</a>

Stewart, S., Playford, D., Scalia, G., Currie, P., Celermajer, D.,Prior, D., Codde, J., Strange, G. (2021). Ejection fraction andmortality: a nationwide register-based cohort study of 499 153women and men. European Journal of Heart Failure, 23(3),406-416. <a href="http://dx.doi.org/10.1002/ejhf.2047">[MoreInformation]</a>

Cao, J., Tran, D., Briody, J., Attard, C., Hassan, E., Simm, P.,Burchill, L., Twigg, S., Fiatarone Singh, M., Ayer, J.,Celermajer, D., Cordina, R., et al (2021). Impact of adiposity onclinical outcomes in people living with a Fontan circulation.International Journal of Cardiology, 329, 82-88. <ahref="http://dx.doi.org/10.1016/j.ijcard.2020.12.066">[MoreInformation]</a>

Celermajer, D. (2021). Inspiratory Muscle Training ImprovesInspiratory Muscle Strength and Functional Exercise Capacityin Pulmonary Arterial Hypertension and ChronicThromboembolic Pulmonary Hypertension: A PilotRandomised Controlled Study. Heart, Lung, and Circulation,30, 388-395. <ahref="http://dx.doi.org/10.1016/j.hlc.2020.06.006">[MoreInformation]</a>

Tran, D., Munoz, P., Lau, E., Alison, J., Brown, M., Zheng, Y.,Corkery, P., Wong, K., Lindstrom, S., Celermajer, D., Davis,G., Cordina, R. (2021). Inspiratory Muscle Training ImprovesInspiratory Muscle Strength and Functional Exercise Capacityin Pulmonary Arterial Hypertension and ChronicThromboembolic Pulmonary Hypertension: A PilotRandomised Controlled Study. Heart, Lung, and Circulation,30(3), 388-395. <ahref="http://dx.doi.org/10.1016/j.hlc.2020.06.006">[MoreInformation]</a>

Femia, J., Zhu, D., Choudhary, P., Ross, S., Muthurangu, V.,Richmond, D., Celermajer, D., Semsarian, C., Puranik, R.(2021). Long term clinical outcomes associated with CMRquantified isolated left ventricular non-compaction in adults.International Journal of Cardiology, 328, 235-240. <ahref="http://dx.doi.org/10.1016/j.ijcard.2020.12.017">[MoreInformation]</a>

Baker, D., Dennis, M., Zannino, D., Schilling, C., Moreno, P.,Bullock, A., Disney, P., Radford, D., Hornung, T., Grigg, L.,Ayer, J., Celermajer, D., Cordina, R., et al (2021). Path aheadfor � low risk' adolescents living with a Fontan circulation.Heart, 107(7), 556-562. <ahref="http://dx.doi.org/10.1136/heartjnl-2020-317619">[MoreInformation]</a>

Sree Raman, K., Shah, R., Stokes, M., Walls, A., Woodman, R.,Perry, R., Walker, J., Proudman, S., De Pasquale, C.,Celermajer, D., et al (2021). Right ventricular myocardialdeoxygenation in patients with pulmonary artery hypertension.Journal of Cardiovascular Magnetic Resonance, 23(1), 22. <ahref="http://dx.doi.org/10.1186/s12968-020-00694-0">[MoreInformation]</a>

Lapirow, D., La Gerche, A., Toro, C., Masango, E., Costello,

B., Porello, E., Ludlow, L., Marshall, G., Trahair, T., Mateos,M., Byrne, J., Celermajer, D., et al (2021). The Australia andNew Zealand Cardio-Oncology Registry: evaluation ofchemotherapy-related cardiotoxicity in a national cohort ofpaediatric cancer patients. Internal Medicine Journal, 51(2),229-234. <a href="http://dx.doi.org/10.1111/imj.14719">[MoreInformation]</a>

Woo, K., Chook, P., Hu, Y., Lao, X., Lin, C., Lee, P., Kwok,C., Wei, A., Guo, D., Yin, Y., Celermajer, D., et al (2021). Theimpact of particulate matter air pollution (PM25) onatherosclerosis in modernizing China: a report from theCATHAY study. International Journal of Epidemiology, 50(2),578-588. <ahref="http://dx.doi.org/10.1093/ije/dyaa235">[MoreInformation]</a>

2020Barraclough, J., Joglekar, M., Januszewski, A., Mart�nez, G.,Celermajer, D., Keech, A., Hardikar, A., Patel, S. (2020). AMicroRNA Signature in Acute Coronary Syndrome Patientsand Modulation by Colchicine. Journal of CardiovascularPharmacology and Therapeutics, 25(5), 444-455. <ahref="http://dx.doi.org/10.1177/1074248420922793">[MoreInformation]</a>

Gondoputro, W., Rajendran, S., Celermajer, D., Qasabian, R.(2020). An unusual case of upper limb ischemia in a marathonrunner. Journal of Vascular Surgery Cases and InnovativeTechniques, 6(1), 160-164. <ahref="http://dx.doi.org/10.1016/j.jvscit.2020.01.017">[MoreInformation]</a>

Lam, M., Hsu, C., Simpson, P., Dunn, L., Chow, R., Chan, K.,Yong, A., Yu, Y., Sieveking, D., Lecce (Venuto), L.,Celermajer, D., Wise, S., Ng, M., et al (2020). AndrogensStimulate EPC-Mediated Neovascularization and AreAssociated with Increased Coronary Collateralization.Endocrinology, 161(5), 1-13. <ahref="http://dx.doi.org/10.1210/endocr/bqaa043">[MoreInformation]</a>

Lim, M., Bannon, P., Celermajer, D. (2020). Bicuspid aorticvalve: Different clinical profiles for subjects with versuswithout repaired aortic coarctation. Open Heart, 7(2), 574. <ahref="http://dx.doi.org/10.1136/openhrt-2020-001429">[MoreInformation]</a>

Tran, D., D'Ambrosio, P., Verrall, C., Attard, C., Briody, J.,D'Souza, M., Fiatarone Singh, M., Ayer, J., d'Udekem, Y.,Twigg, S., Davis, G., Celermajer, D., Cordina, R. (2020). BodyComposition in Young Adults Living With a FontanCirculation: The Myopenic Profile. Journal of the AmericanHeart Association, 9, 1-15. <ahref="http://dx.doi.org/10.1161/JAHA.119.015639">[MoreInformation]</a>

Moore, B., Cao, J., Cordina, R., McGuire, M., Celermajer, D.(2020). Defibrillators in adult congenital heart disease: Long-term risk of appropriate shocks, inappropriate shocks, andcomplications. Pacing And Clinical Electrophysiology, 43(7),746-753. <ahref="http://dx.doi.org/10.1111/pace.13974">[MoreInformation]</a>

Khou, V., Anderson, J., Strange, G., Corrigan, C., Collins, N.,Celermajer, D., Dwyer, N., Feenstra, J., Horrigan, M., Keating,D., Lau, E., et al (2020). Diagnostic delay in pulmonary arterialhypertension: Insights from the Australian and New Zealandpulmonary hypertension registry. Respirology, 25(8), 863-871.<a href="http://dx.doi.org/10.1111/resp.13768">[MoreInformation]</a>

Khuong, J., Wilson, T., Grigg, L., Bullock, A., Celermajer, D.,

Disney, P., Wijesekera, V., Hornung, T., Zannino, D., Iyengar,A., et al (2020). Fontan-associated nephropathy: Predictors andoutcomes. International Journal of Cardiology, 306, 73-77. <ahref="http://dx.doi.org/10.1016/j.ijcard.2020.01.014">[MoreInformation]</a>

Marshall, K., d'Udekem, Y., Sholler, G., Opotowsky, A., Costa,D., Sharpe, L., Celermajer, D., Winlaw, D., Newburger, J.,Kasparian, N. (2020). Health-Related Quality of Life inChildren, Adolescents, and Adults With a Fontan Circulation: AMeta-Analysis. Journal of the American Heart Association,9(6), e014172. <ahref="http://dx.doi.org/10.1161/JAHA.119.014172">[MoreInformation]</a>

Marathe, S., Zannino, D., Cao, J., du Plessis, K., Marathe, S.,Ayer, J., Celermajer, D., Gentles, T., Sholler, G., Justo, R.,Winlaw, D., et al (2020). Heterotaxy Is Not a Risk Factor forAdverse Long-Term Outcomes After Fontan Completion.Annals of Thoracic Surgery, 110(2), 646-653. <ahref="http://dx.doi.org/10.1016/j.athoracsur.2019.11.015">[More Information]</a>

Celermajer, D., Offen, S. (2020). Is vWF really a verywonderful factor for risk stratification in adults with congenitalheart disease? Heart, 106(12), 876-877. <ahref="http://dx.doi.org/10.1136/heartjnl-2020-316599">[MoreInformation]</a>

Raman, K., Shah, R., Stokes, M., Walls, A., Woodman, R.,Ananthakrishna, R., Walker, J., Proudman, S., Steele, P., DePasquale, C., Celermajer, D., et al (2020). Left ventricularischemia in pre-capillary pulmonary hypertension: acardiovascular magnetic resonance study. CardiovascularDiagnosis and Therapy, 10(5), 1280-1292. <ahref="http://dx.doi.org/10.21037/cdt-20-698">[MoreInformation]</a>

Femia, J., Semsarian, C., Ross, S., Celermajer, D., Puranik, R.(2020). Left ventricular non-compaction: Review of the currentdiagnostic challenges and consequences in athletes. Medicina,56(12), 1-10. <ahref="http://dx.doi.org/10.3390/medicina56120697">[MoreInformation]</a>

Opotowsky, A., Celermajer, D., Rhodes, J. (2020). Letter byOpotowsky et al Regarding Article, "results of the FUEL Trial".Circulation, 142(4), E38-E39. <ahref="http://dx.doi.org/10.1161/CIRCULATIONAHA.119.045205">[More Information]</a>

Strange, G., Stewart, S., Farthing, M., Kasparian, N., Selbie, L.,O'Donnell, C., Ayer, J., Cordina, R., Celermajer, D. (2020).Living With, and Caring for, Congenital Heart Disease inAustralia: Insights From the Congenital Heart Alliance ofAustralia and New Zealand Online Survey. Heart, Lung, andCirculation, 29(2), 216-223. <ahref="http://dx.doi.org/10.1016/j.hlc.2018.12.009">[MoreInformation]</a>

Zentner, D., Celermajer, D., Gentles, T., d'Udekem, Y., Ayer,J., Blue, G., Bridgman, C., Burchill, L., Cheung, M., Cordina,R., McGuire, M., Moore, B., Sholler, G., Winlaw, D., et al(2020). Management of People With a Fontan Circulation: aCardiac Society of Australia and New Zealand Positionstatement. Heart, Lung, and Circulation, 29(1), 5-39. <ahref="http://dx.doi.org/10.1016/j.hlc.2019.09.010">[MoreInformation]</a>

Arnott, C., Nelson, M., Alfaro Ramirez, M., Hyett, J., Gale, M.,Henry, A., Celermajer, D., Taylor, L., Woodward, M. (2020).Maternal cardiovascular risk after hypertensive disorder ofpregnancy. Heart, 106(24), 1927-1933. <ahref="http://dx.doi.org/10.1136/heartjnl-2020-316541">[MoreInformation]</a>

Poh, C., Hornung, T., Celermajer, D., Radford, D., Justo, R.,Andrews, D., du Plessis, K., Iyengar, A., Winlaw, D.,d'Udekem, Y. (2020). Modes of late mortality in patients with aFontan circulation. Heart, 106(18), 1427-1431. <ahref="http://dx.doi.org/10.1136/heartjnl-2019-315862">[MoreInformation]</a>

Marathe, S., Cao, J., Celermajer, D., Ayer, J., Sholler, G.,d'Udekem, Y., Winlaw, D. (2020). Outcomes of the FontanOperation for Patients With Heterotaxy: A Meta-Analysis of848 Patients. Annals of Thoracic Surgery, 110(1), 307-315. <ahref="http://dx.doi.org/10.1016/j.athoracsur.2019.11.027">[More Information]</a>

Moore, B., Medi, C., McGuire, M., Celermajer, D., Cordina, R.(2020). Pacing-associated cardiomyopathy in adult congenitalheart disease. Open Heart, 7(2), e001374. <ahref="http://dx.doi.org/10.1136/openhrt-2020-001374">[MoreInformation]</a>

Anderson, J., Lavender, M., Lau, E., Celermajer, D., Collins,N., Dwyer, N., Feenstra, J., Horrigan, M., Keating, D., Keogh,A., et al (2020). Pharmacological Treatment of PulmonaryArterial Hypertension in Australia: Current Trends andChallenges. Heart, Lung, and Circulation, 29(10), 1459-1468.<a href="http://dx.doi.org/10.1016/j.hlc.2020.01.017">[MoreInformation]</a>

Playford, D., Stewart, S., Celermajer, D., Prior, D., Scalia, G.,Marwick, T., Ilton, M., Codde, J., Strange, G. (2020). PoorSurvival with Impaired Valvular Hemodynamics After AorticValve Replacement: The National Echo Database AustraliaStudy. Journal of the American Society of Echocardiography,33(9), 1077-1086.e1. <ahref="http://dx.doi.org/10.1016/j.echo.2020.04.024">[MoreInformation]</a>

Ratwatte, S., Anderson, J., Strange, G., Corrigan, C., Collins,N., Celermajer, D., Dwyer, N., Feenstra, J., Keating, D.,Kotlyar, E., Lau, E., et al (2020). Pulmonary arterialhypertension with below threshold pulmonary vascularresistance. European Respiratory Journal, 56(1), 1901654. <ahref="http://dx.doi.org/10.1183/13993003.01654-2019">[MoreInformation]</a>

Tran, D., Maiorana, A., Ayer, J., Lubans, D., Davis, G.,Celermajer, D., d'Udekem, Y., Cordina, R. (2020).Recommendations for exercise in adolescents and adults withcongenital heart disease. Progress In Cardiovascular Diseases,63(3), 350-366. <ahref="http://dx.doi.org/10.1016/j.pcad.2020.03.002">[MoreInformation]</a>

Cao, J., Wales, K., Zhao, D., Seco, M., Celermajer, D., Bannon,P. (2020). Repair of Less Than Severe Tricuspid Regurgitationduring Left Sided Valve Surgery: A Meta-Analysis. Annals ofThoracic Surgery, 109(3), 950-958. <ahref="http://dx.doi.org/10.1016/j.athoracsur.2019.08.101">[More Information]</a>

Anderson, J., Lau, E., Lavender, M., Benza, R., Celermajer, D.,Collins, N., Corrigan, C., Dwyer, N., Feenstra, J., Horrigan, M.,et al (2020). Retrospective Validation of the REVEAL 2.0 RiskScore with the Australian and New Zealand PulmonaryHypertension Registry Cohort. Chest, 157(1), 162-172. <ahref="http://dx.doi.org/10.1016/j.chest.2019.08.2203">[MoreInformation]</a>

Rashid, I., Mahmood, A., Ismail, T., O'Meagher, S., Kutty, S.,Celermajer, D., Puranik, R. (2020). Right ventricular systolicdysfunction but not dilatation correlates with prognosticallysignificant reductions in exercise capacity in repaired Tetralogyof Fallot. European Heart Journal - Cardiovascular Imaging,21(8), 906-913. <a

href="http://dx.doi.org/10.1093/ehjci/jez245">[MoreInformation]</a>

Kay, S., Moore, B., Seco, M., Marshman, D., Grieve, S.,Celermajer, D. (2020). Rugby Player's Aorta: AlarmingPrevalence of Ascending Aortic Dilatation and Effacement inElite Rugby Players. Heart, Lung, and Circulation, 29(2), 196-201. <ahref="http://dx.doi.org/10.1016/j.hlc.2019.06.714">[MoreInformation]</a>

Nanayakkara, B., Lau, E., Yee, B., Gauthier, G., Melehan, K.,Celermajer, D., Cordina, R. (2020). Sleep disordered breathingin adults living with a Fontan circulation and CPAP titrationprotocol. International Journal of Cardiology, 317, 70-74. <ahref="http://dx.doi.org/10.1016/j.ijcard.2020.05.060">[MoreInformation]</a>

Woo, K., Hu, Y., Chook, P., Wei, A., Wu, M., Li, L., Woo, J.,Chan, T., Cheng, W., Celermajer, D. (2020). The Impact ofLifestyle Changes on Cardiometabolic Health in ModernizingChina: A Tale of Three Gorges in the Yangtze River. MetabolicSyndrome and Related Disorders, 18(1), 65-71. <ahref="http://dx.doi.org/10.1089/met.2019.0027">[MoreInformation]</a>

Waldmann, V., Combes, N., Ladouceur, M., Celermajer, D.,Iserin, L., Gatzoulis, M., Khairy, P., Marijon, E. (2020).Understanding Electrocardiography in Adult Patients WithCongenital Heart Disease: A Review. JAMA Cardiology, 5(12),1435-1444. <ahref="http://dx.doi.org/10.1001/jamacardio.2020.3416">[MoreInformation]</a>

Cai, T., Meroni, A., Dissanayake, H., Phang, M., Aviolo, A.,Celermajer, D., Butlin, M., Skilton, M., Qasem, A. (2020).Validation of a cuff-based device for measuring carotid-femoralpulse wave velocity in children and adolescents. Journal ofHuman Hypertension, 34(4), 311-318. <ahref="http://dx.doi.org/10.1038/s41371-019-0191-1">[MoreInformation]</a>

Arnott, C., Patel, S., Hyett, J., Jennings, G., Woodward, M.,Celermajer, D. (2020). Women and Cardiovascular Disease:Pregnancy, the Forgotten Risk Factor. Heart, Lung, andCirculation, 29(5), 662-667. <ahref="http://dx.doi.org/10.1016/j.hlc.2019.09.011">[MoreInformation]</a>

Baker, D., Celermajer, D. (2020). Would increasing stress onthe heart decrease stress on the doctor? Decision-making inasymptomatic pulmonary regurgitation. Heart, 107(3), 180-182.<a href="http://dx.doi.org/10.1136/heartjnl-2020-318349">[More Information]</a>

2019Woo, K., Hu, Y., Chook, P., Wei, A., Chan, R., Yin, Y.,Celermajer, D. (2019). A Tale of Three Gorges in the YangtzeRiver: Comparing the Prevalence of Metabolic SyndromeAccording to ATPIII, WHO, and IDF Criteria and theAssociation with Vascular Health in Modernizing China.Metabolic Syndrome and Related Disorders, 17(3), 137-142. <ahref="http://dx.doi.org/10.1089/met.2018.0091">[MoreInformation]</a>

Nicolae, M., Gentles, T., Strange, G., Tanous, D., Disney, P.,Bullock, A., Grigg, L., Chen, S., Pressley, L., Cordina, R.,Celermajer, D., et al (2019). Adult Congenital Heart Disease inAustralia and New Zealand A Call for Optimal Care. Heart,Lung, and Circulation, 28(4), 521-529. <ahref="http://dx.doi.org/10.1016/j.hlc.2018.10.015">[MoreInformation]</a>

Callaghan, F., Bannon, P., Barin, E., Celermajer, D., Jeremy,

R., Figtree, G., Grieve, S. (2019). Age-related changes of shapeand flow dynamics in healthy adult aortas: A 4D flow MRIstudy. Journal of Magnetic Resonance Imaging, 49(1), 90-100.<a href="http://dx.doi.org/10.1002/jmri.26210">[MoreInformation]</a>

King, G., Ayer, J., Celermajer, D., Zentner, D., Justo, R.,Disney, P., Zannino, D., d�Udekem, Y. (2019).Atrioventricular Valve Failure in Fontan�Palliation. Journalof the American College of Cardiology, 73(7), 810-822. <ahref="http://dx.doi.org/10.1016/j.jacc.2018.12.025">[MoreInformation]</a>

Shearer, L., Justo, R., Marathe, S., Betts, K., Venugopal, P.,Winlaw, D., Bullock, A., Robertson, T., Gentles, T.,Celermajer, D., et al (2019). Augmentation of the pulmonaryarteries at or prior to the Fontan procedure is not associatedwith worse long-term outcomes: a propensity-matched analysisfrom the Australia-New Zealand Fontan Registry. EuropeanJournal Of Cardio-Thoracic Surgery, 55(5), 829-836. <ahref="http://dx.doi.org/10.1093/ejcts/ezy376">[MoreInformation]</a>

Kott, K., Vernon, S., Hansen, T., Yu, C., Bubb, K., Coffey, S.,Sullivan, D., Yang, J., O'Sullivan, J., Chow, C., Patel, S.,Chong, J., Celermajer, D., Kritharides, L., Grieve, S., Figtree,G. (2019). Biobanking for discovery of novel cardiovascularbiomarkers using imaging-quantified disease burden: protocolfor the longitudinal, prospective, BioHEART-CT cohort study.BMJ Open, 9(9), 1-9. <ahref="http://dx.doi.org/10.1136/bmjopen-2018-028649">[MoreInformation]</a>

Jouven, X., Diop, B., Narayanan, K., Adoubi, A., Ba, S., Balde,D., Damorou, J., Diarra, M., Dzudie, A., Ferreira, B.,Celermajer, D., et al (2019). Cardiac Pacing in Sub-SaharanAfrica: JACC International. Journal of the American College ofCardiology, 74(21), 2652-2660. <ahref="http://dx.doi.org/10.1016/j.jacc.2019.09.034">[MoreInformation]</a>

Chiesa, S., Masi, S., Shipley, M., Ellins, E., Fraser, A., Hughes,A., Patel, R., Khir, A., Halcox, J., Singh-Manoux, A.,Celermajer, D., et al (2019). Carotid artery wave intensity inmid- to late-life predicts cognitive decline: the Whitehall IIstudy. European Heart Journal, 40(28), 2300-2309. <ahref="http://dx.doi.org/10.1093/eurheartj/ehz189">[MoreInformation]</a>

Gallagher, R., Chow, C., Parker, H., Neubeck, L., Celermajer,D., Redfern, J., Tofler, G., Buckley, T., Schumacher, T., Ferry,C., Whitley, A., Figtree, G., et al (2019). Design and rationaleof the MyHeartMate study: a randomised controlled trial of agame-based app to promote behaviour change in patients withcardiovascular disease. BMJ Open, 9(5), 1-7. <ahref="http://dx.doi.org/10.1136/bmjopen-2018-024269">[MoreInformation]</a>

Barraclough, J., Skilton, M., Garden, F., Toelle, B., Marks, G.,Celermajer, D. (2019). Early and late childhood telomere lengthpredict subclinical atherosclerosis at age 14 yrs. - TheCardioCAPS study. International Journal of Cardiology, 278,250-253. <ahref="http://dx.doi.org/10.1016/j.ijcard.2018.12.065">[MoreInformation]</a>

Moore, B., Cordina, R., McGuire, M., Celermajer, D. (2019).Efficacy and adverse effects of sotalol in adults with congenitalheart disease. International Journal of Cardiology, 274, 74-79.<a href="http://dx.doi.org/10.1016/j.ijcard.2018.06.066">[MoreInformation]</a>

Raman, K., Stokes, M., Walls, A., Perry, R., Steele, P.,Burdeniuk, C., De Pasquale, C., Celermajer, D., Selvanayagam,J. (2019). Feasibility of oxygen sensitive cardiac magnetic

resonance of the right ventricle in pulmonary arteryhypertension. Cardiovascular Diagnosis and Therapy, 9(5),502-512. <ahref="http://dx.doi.org/10.21037/cdt.2019.09.19">[MoreInformation]</a>

Simonneau, G., Montani, D., Celermajer, D., Denton, C.,Gatzoulis, M., Krowka, M., Williams, P., Souza, R. (2019).Haemodynamic definitions and updated clinical classificationof pulmonary hypertension. European Respiratory Journal,53(1), 1-13. <ahref="http://dx.doi.org/10.1183/13993003.01913-2018">[MoreInformation]</a>

Dennis, M., Cusick, A., Borilovic, J., Nicholson, C., Derwin,T., Puranik, R., Celermajer, D. (2019). Left arm structure andfunction late after subclavian flap repair of aortic coarctation inchildhood. Cardiology in the Young, 29(7), 856-861. <ahref="http://dx.doi.org/10.1017/S1047951119000386">[MoreInformation]</a>

Choudhary, P., Strugnell, W., Puranik, R., Hamilton-Craig, C.,Kutty, S., Celermajer, D. (2019). Left ventricular non-compaction in patients with single ventricle heart disease.Cardiology in the Young, 30(1), 12-18. <ahref="http://dx.doi.org/10.1017/S1047951119001872">[MoreInformation]</a>

Skilton, M., Celermajer, D., Cosmi, E., Crispi, F., Gidding, S.,Raitakari, O., Urbina, E. (2019). Natural History ofAtherosclerosis and Abdominal Aortic Intima-MediaThickness: Rationale, Evidence, and Best Practice for Detectionof Atherosclerosis in the Young. Journal of Clinical Medicine,8(8), 1-20. <ahref="http://dx.doi.org/10.3390/jcm8081201">[MoreInformation]</a>

Poh, C., Celermajer, D., Grigg, L., Kalman, J., McGuire, M.,Gentles, T., Radford, D., Bullock, A., Disney, P., Winlaw, D.,et al (2019). Pacemakers are associated with a higher risk oflate death and transplantation in the Fontan population.International Journal of Cardiology, 282, 33-37. <ahref="http://dx.doi.org/10.1016/j.ijcard.2019.01.088">[MoreInformation]</a>

Strange, G., Stewart, S., Celermajer, D., Prior, D., Scalia, G.,Marwick, T., Ilton, M., Joseph, M., Codde, J., Playford, D.(2019). Poor Long-term Survival in Patients with ModerateAortic Stenosis. Journal of the American College ofCardiology, 74(15), 1851-1863. <ahref="http://dx.doi.org/10.1016/j.jacc.2019.08.004">[MoreInformation]</a>

D'Ambrosio, P., Tran, D., Verrall, C., Attard, C., FiataroneSingh, M., Ayer, J., d'Udekem, Y., Twigg, S., Celermajer, D.,Cordina, R. (2019). Prevalence and risk factors for low bonedensity in adults with a Fontan circulation. Congenital HeartDisease, 14(6), 987-995. <ahref="http://dx.doi.org/10.1111/chd.12836">[MoreInformation]</a>

Gnappa, G., Celermajer, D., Zhu, D., Puranik, R., Ayer, J.(2019). Severe right ventricular dilatation after repair ofTetralogy of Fallot is associated with increased left ventricularpreload and stroke volume. European Heart Journal -Cardiovascular Imaging, 20(9), 1020-1026. <ahref="http://dx.doi.org/10.1093/ehjci/jez035">[MoreInformation]</a>

Cordina, R., Playford, D., Lang, I., Celermajer, D. (2019). State-of-the-Art Review: Echocardiography in PulmonaryHypertension. Heart, Lung, and Circulation, 28(9), 1351-1364.<a href="http://dx.doi.org/10.1016/j.hlc.2019.03.003">[MoreInformation]</a>

Tarp, J., Sorgaard, M., Christoffersen, C., Jensen, A., Sillesen,H., Celermajer, D., Eriksson, P., Estensen, M., Nagy, E.,Holstein-Rathlou, N., et al (2019). Subclinical atherosclerosis inpatients with cyanotic congenital heart disease. InternationalJournal of Cardiology, 277, 97-103. <ahref="http://dx.doi.org/10.1016/j.ijcard.2018.08.104">[MoreInformation]</a>

Witte, K., Lipiecki, J., Siminiak, T., Meredith, I., Malkin, C.,Goldberg, S., Stark, M., von Bardeleben, R., Cremer, P., Jaber,W., Celermajer, D., et al (2019). The REDUCE FMR Trial: ARandomized Sham-Controlled Study of Percutaneous MitralAnnuloplasty in Functional Mitral Regurgitation. JACC: HeartFailure, 7(11), 945-955. <ahref="http://dx.doi.org/10.1016/j.jchf.2019.06.011">[MoreInformation]</a>

Strange, G., Stewart, S., Celermajer, D., Prior, D., Scalia, G.,Marwick, T., Gabbay, E., Ilton, M., Joseph, M., Codde, J., et al(2019). Threshold of Pulmonary Hypertension Associated WithIncreased Mortality. Journal of the American College ofCardiology, 73(21), 2660-2672. <ahref="http://dx.doi.org/10.1016/j.jacc.2019.03.482">[MoreInformation]</a>

Wang, N., Fulcher, J., Abeysuriya, N., McGrady, M., Wilcox,I., Celermajer, D., Lal, S. (2019). Tricuspid regurgitation isassociated with increased mortality independent of pulmonarypressures and right heart failure: a systematic review and meta-analysis. European Heart Journal, 40(5), 476-484. <ahref="http://dx.doi.org/10.1093/eurheartj/ehy641">[MoreInformation]</a>

Barraclough, J., Garden, F., Toelle, B., Marks, G., Baur, L.,Ayer, J., Celermajer, D. (2019). Weight Gain Trajectories fromBirth to Adolescence and Cardiometabolic Status inAdolescence. The Journal of Pediatrics, 208, 89-95.e4. <ahref="http://dx.doi.org/10.1016/j.jpeds.2018.12.034">[MoreInformation]</a>

2018Moore, B., Anderson, R., Nisbet, A., Kalla, M., du Plessis, K.,d'Udekem, Y., Bullock, A., Cordina, R., Grigg, L., Celermajer,D., McGuire, M., et al (2018). Ablation of Atrial ArrhythmiasAfter the Atriopulmonary Fontan Procedure: Mechanisms ofArrhythmia and Outcomes. JACC: Clinical Electrophysiology,4(10), 1338-1346. <ahref="http://dx.doi.org/10.1016/j.jacep.2018.08.012">[MoreInformation]</a>

Moore, B., Cordina, R., McGuire, M., Celermajer, D. (2018).Adverse effects of amiodarone therapy in adults with congenitalheart disease. Congenital Heart Disease, 13(6), 944-951. <ahref="http://dx.doi.org/10.1111/chd.12657">[MoreInformation]</a>

Celermajer, D. (2018). Atrial septal defects: Even simplecongenital heart diseases can be complicated. European HeartJournal, 39(12), 999-1001. <ahref="http://dx.doi.org/10.1093/eurheartj/ehx633">[MoreInformation]</a>

Dissanayake, H., McMullan, R., Kong, Y., Caterson, I.,Celermajer, D., Phang, M., Raynes-Greenow, C., Polson, J.,Gordon, A., Skilton, M. (2018). Body Fatness andCardiovascular Health in Newborn Infants. Journal of ClinicalMedicine, 7(9), 1-12. <ahref="http://dx.doi.org/10.3390/jcm7090270">[MoreInformation]</a>

O'Brien, E., Law, D., Celermajer, D., Grant, P., Waites, J.(2018). Caring for adults with congenital heart disease in aregional setting. Australian Journal of Rural Health, 26(6), 441-446. <a href="http://dx.doi.org/10.1111/ajr.12446">[More

Information]</a>

Yu, C., Moore, B., Kotchetkova, I., Cordina, R., Celermajer, D.(2018). Causes of death in a contemporary adult congenitalheart disease cohort. Heart, 104(20), 1678-1682. <ahref="http://dx.doi.org/10.1136/heartjnl-2017-312777">[MoreInformation]</a>

Chong, L., Fitzgerald, D., Craig, J., Manera, K., Hanson, C.,Celermajer, D., Ayer, J., Kasparian, N., Tong, A. (2018).Children's experiences of congenital heart disease: a systematicreview of qualitative studies. European Journal of Pediatrics,177(3), 319-336. <a href="http://dx.doi.org/10.1007/s00431-017-3081-y">[More Information]</a>

Dennis, M., Zannino, D., du Plessis, K., Bullock, A., Disney, P.,Radford, D., Hornung, T., Grigg, L., Cordina, R., d'Udekem,Y., Celermajer, D. (2018). Clinical Outcomes in Adolescentsand Adults After the Fontan Procedure. Journal of theAmerican College of Cardiology, 71(9), 1009-1017. <ahref="http://dx.doi.org/10.1016/j.jacc.2017.12.054">[MoreInformation]</a>

Garden, F., Toelle, B., Mihrshahi, S., Webb, K., Almqvist, C.,Tovey, E., Brew, B., Ayer, J., Skilton, M., Jones, G., Cowie, C.,Britton, W., Celermajer, D., Leeder, S., Peat, J., Marks, G., et al(2018). Cohort profile: The Childhood Asthma PreventionStudy (CAPS). International Journal of Epidemiology, 47(6),1736a-1736k. <ahref="http://dx.doi.org/10.1093/ije/dyy078">[MoreInformation]</a>

Vaidya, K., Arnott, C., Martinez, G., Ng, B., McCormack, S.,Sullivan, D., Celermajer, D., Patel, S. (2018). ColchicineTherapy and Plaque Stabilization in Patients WithAcute�Coronary Syndrome: A CT Coronary AngiographyStudy. JACC: Cardiovascular Imaging, 11(2), 305-316. <ahref="http://dx.doi.org/10.1016/j.jcmg.2017.08.013">[MoreInformation]</a>

Vaidya, K., Khandkar, C., Celermajer, D. (2018). Currentmanagement aspects in adult congenital heart disease: Non-surgical closure of patent foramen ovale. CardiovascularDiagnosis and Therapy, 8(6), 739-753. <ahref="http://dx.doi.org/10.21037/cdt.2018.09.09">[MoreInformation]</a>

Cao, J., Lee, S., Phan, K., Ayer, J., Celermajer, D., Winlaw, D.(2018). Early Outcomes of Hypoplastic Left Heart SyndromeInfants: Meta-Analysis of Studies Comparing the Hybrid andNorwood Procedures. World Journal for Pediatric andCongenital Heart Surgery, 9(2), 224-233. <ahref="http://dx.doi.org/10.1177/2150135117752896">[MoreInformation]</a>

Cordina, R., Ministeri, M., Babu-Narayan, S., Ladouceur, M.,Celermajer, D., Gatzoulis, M., Uebing, A., Li, W. (2018).Evaluation of the relationship between ventricular end-diastolicpressure and echocardiographic measures of diastolic functionin adults with a Fontan circulation. International Journal ofCardiology, 259, 71-75. <ahref="http://dx.doi.org/10.1016/j.ijcard.2018.02.045">[MoreInformation]</a>

Wong, J., Chabiniok, R., Tibby, S., Pushparajah, K., Sammut,E., Celermajer, D., Giese, D., Hussain, T., Greil, G., Schaeffter,T., et al (2018). Exploring kinetic energy as a new marker ofcardiac function in the single ventricle circulation. Journal ofApplied Physiology, 125(3), 889-900. <ahref="http://dx.doi.org/10.1152/japplphysiol.00580.2017">[More Information]</a>

Harmer, J., Keech, A., Veillard, A., Skilton, M., Watts, G.,Celermajer, D. (2018). Fenofibrate effects on carotid arteryintima-media thickness in adults with type 2 diabetes mellitus: a

FIELD substudy. Diabetes Research and Clinical Practice,141, 156-167. <ahref="http://dx.doi.org/10.1016/j.diabres.2018.05.006">[MoreInformation]</a>

Marijon, E., Celermajer, D., Jouven, X. (2018). Global Burdenof Rheumatic Heart Disease. New England Journal ofMedicine, 378(1), e2. <ahref="http://dx.doi.org/10.1056/NEJMc1714503">[MoreInformation]</a>

Lal, S., Kotchetkova, I., Cao, J., Jackson, D., Cordina, R.,Celermajer, D. (2018). Heart failure admissions and poorsubsequent outcomes in adults with congenital heart disease.European Journal of Heart Failure, 20(4), 812-815. <ahref="http://dx.doi.org/10.1002/ejhf.1051">[MoreInformation]</a>

Wilson, T., d'Udekem, Y., Winlaw, D., Cordina, R.,Celermajer, D., Wheaton, G., Bullock, A., Gentles, T.,Weintraub, R., Justo, R., Ayer, J., et al (2018). Hepatic andrenal end-organ damage in the Fontan circulation: A reportfrom the Australian and New Zealand Fontan Registry.International Journal of Cardiology, 273, 100-107. <ahref="http://dx.doi.org/10.1016/j.ijcard.2018.07.118">[MoreInformation]</a>

Neidenbach, R., Niwa, K., Oto, O., Oechslin, E., Aboulhosn, J.,Celermajer, D., Schelling, J., Pieper, L., Sanftenberg, L.,Oberhoffer, R., et al (2018). Improving medical care andprevention in adults with congenital heart disease�reflectionson a global problem�part I: Development of congenitalcardiology, epidemiology, clinical aspects, heart failure, cardiacarrhythmia. Cardiovascular Diagnosis and Therapy, 8(6), 705-715. <ahref="http://dx.doi.org/10.21037/cdt.2018.10.15">[MoreInformation]</a>

Neidenbach, R., Niwa, K., Oto, O., Oechslin, E., Aboulhosn, J.,Celermajer, D., Schelling, J., Pieper, L., Sanftenberg, L.,Oberhoffer, R., et al (2018). Improving medical care andprevention in adults with congenital heart disease�reflectionson a global problem�part II: Infective endocarditis,pulmonary hypertension, pulmonary arterial hypertension andaortopathy. Cardiovascular Diagnosis and Therapy, 8(6), 716-724. <ahref="http://dx.doi.org/10.21037/cdt.2018.10.16">[MoreInformation]</a>

Gerges, C., Gerges, M., Fesler, P., Pistritto, A., Konowitz, N.,Jakowitsch, J., Celermajer, D., Lang, I. (2018). In-depthhemodynamic phenotyping of pulmonary hypertension due toleft heart disease. European Respiratory Journal, 51(5), 1-12.<a href="http://dx.doi.org/10.1183/13993003.00067-2018">[More Information]</a>

Moore, B., Yu, C., Kotchetkova, I., Cordina, R., Celermajer, D.(2018). Incidence and clinical characteristics of sudden cardiacdeath in adult congenital heart disease. International Journal ofCardiology, 254, 101-106. <ahref="http://dx.doi.org/10.1016/j.ijcard.2017.11.117">[MoreInformation]</a>

Spencer, L., Zafiropoulos, B., Denniss, W., Fowler, D., Alison,J., Celermajer, D. (2018). Is there a learning effect when the 6-minute walk test is repeated in people with suspectedpulmonary hypertension? Chronic Respiratory Disease, 15(4),339-346. <ahref="http://dx.doi.org/10.1177/1479972317752762">[MoreInformation]</a>

Chung, K., Strange, G., Codde, J., Celermajer, D., Scalia, G.,Playford, D. (2018). Left Heart Disease and PulmonaryHypertension: Are We Seeing the Full Picture? Heart, Lung,and Circulation, 27(3), 301-309. <a

href="http://dx.doi.org/10.1016/j.hlc.2017.09.015">[MoreInformation]</a>

Cao, J., Phan, K., Ayer, J., Celermajer, D., Winlaw, D. (2018).Long term survival of hypoplastic left heart syndrome infants:Meta-analysis comparing outcomes from the modifiedBlalock�Taussig shunt and the right ventricle to pulmonaryartery shunt. International Journal of Cardiology, 254, 107-116. <ahref="http://dx.doi.org/10.1016/j.ijcard.2017.10.040">[MoreInformation]</a>

Dennis, M., Kotchetkova, I., Cordina, R., Celermajer, D.(2018). Long-Term Follow-up of Adults Following the AtrialSwitch Operation for Transposition of the Great Arteries - AContemporary Cohort. Heart, Lung, and Circulation, 27(8),1011-1017. <ahref="http://dx.doi.org/10.1016/j.hlc.2017.10.008">[MoreInformation]</a>

Elias, P., Poh, C., du Plessis, K., Zannino, D., Rice, K.,Radford, D., Bullock, A., Wheaton, G., Celermajer, D.,d�Udekem, Y. (2018). Long-term outcomes of single-ventricle palliation for pulmonary atresia with intact ventricularseptum: Fontan survivors remain at risk of late myocardialischaemia and death. European Journal Of Cardio-ThoracicSurgery, 53(6), 1230-1236. <ahref="http://dx.doi.org/10.1093/ejcts/ezy038">[MoreInformation]</a>

Cordina, R., Celermajer, D., d�Udekem, Y. (2018). Lowerlimb exercise generates pulsatile flow into the pulmonaryvascular bed in the setting of the Fontan circulation. Cardiologyin the Young, 28(5), 732-733. <ahref="http://dx.doi.org/10.1017/S104795111800015X">[MoreInformation]</a>

Cordina, R., Ahmad, S., Kotchetkova, I., Eveborn, G., Pressley,L., Ayer, J., Chard, R., Tanous, D., Robinson, P., Kilian, J.,Celermajer, D., et al (2018). Management errors in adults withcongenital heart disease: prevalence, sources, andconsequences. European Heart Journal, 39(12), 982-989. <ahref="http://dx.doi.org/10.1093/eurheartj/ehx685">[MoreInformation]</a>

Dissanayake, H., McMullan, R., Gordon, A., Caterson, I.,Celermajer, D., Phang, M., Raynes-Greenow, C., Skilton, M.,Polson, J. (2018). Noninvasive assessment of autonomicfunction in human neonates born at the extremes of fetal growthspectrum. Physiological Reports, 6(8), e13682. <ahref="http://dx.doi.org/10.14814/phy2.13682">[MoreInformation]</a>

Tran, D., Lau, E., Celermajer, D., Davis, G., Cordina, R.(2018). Pathophysiology of exercise intolerance in pulmonaryarterial hypertension. Respirology, 23(2), 148-159. <ahref="http://dx.doi.org/10.1111/resp.13141">[MoreInformation]</a>

Cao, J., Wales, K., Cordina, R., Lau, E., Celermajer, D. (2018).Pulmonary vasodilator therapies are of no benefit in pulmonaryhypertension due to left heart disease: A meta-analysis.International Journal of Cardiology, 273, 213-220. <ahref="http://dx.doi.org/10.1016/j.ijcard.2018.09.043">[MoreInformation]</a>

Arnott, C., Strange, G., Bullock, A., Kirby, A., O'Donnell, C.,Radford, D., Grigg, L., Celermajer, D. (2018). Pulmonaryvasodilator therapy is associated with greater survival inEisenmenger syndrome. Heart, 104(9), 732-737. <ahref="http://dx.doi.org/10.1136/heartjnl-2017-311876">[MoreInformation]</a>

Melehan, K., Hoyos, C., Hamilton, G., Wong, K., Yee, B.,McLachlan, R., O'Meagher, S., Celermajer, D., Ng, M.,

Grunstein, R., et al (2018). Randomised trial of CPAP andVardenafil on erectile and arterial function in men withobstructive sleep apnea and erectile dysfunction. The Journal ofClinical Endocrinology and Metabolism, 103(4), 1601-1611. <ahref="http://dx.doi.org/10.1210/jc.2017-02389">[MoreInformation]</a>

Li, A., Celermajer, D., Chan, M., Sung, R., Woo, K. (2018).Reference range for brachial artery flow-mediated dilation inhealthy Chinese children and adolescents. Hong Kong MedicalJournal, 24 Suppl 3(3), 36-38.

Cao, J., Lee, S., Phan, K., Celermajer, D., Lal, S. (2018). Renin-angiotensin-aldosterone inhibition improves right ventricularfunction: a meta-analysis. Heart Asia, 10(1), 1-7. <ahref="http://dx.doi.org/10.1136/heartasia-2018-010999">[MoreInformation]</a>

Martinez, G., Celermajer, D., Patel, S. (2018). Reply to:Inhibitory effects of colchicine on inflammasomes"".Atherosclerosis, 273, 155-156. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2018.03.042">[More Information]</a>

Gnanappa, G., Rashid, I., Celermajer, D., Ayer, J., Puranik, R.(2018). Reproducibility of Cardiac Magnetic ResonanceImaging (CMRI)-Derived Right Ventricular Parameters inRepaired Tetralogy of Fallot (ToF). Heart, Lung, andCirculation, 27(3), 381-385. <ahref="http://dx.doi.org/10.1016/j.hlc.2017.04.017">[MoreInformation]</a>

Morton, J., Bao, B., Vanags, L., Tsatralis, T., Ridiandries, A.,Siu, C., Ng, K., Tan, J., Celermajer, D., Ng, M., Bursill, C.(2018). Strikingly Different Atheroprotective Effects ofApolipoprotein A-I in Early-Versus Late-Stage Atherosclerosis.JACC: Basic to Translational Science, 3(2), 187-199. <ahref="http://dx.doi.org/10.1016/j.jacbts.2017.11.004">[MoreInformation]</a>

Skoro-Sajer, N., Gerges, C., Hajnalka Balint, O., Kohalmi, D.,Kaldararova, M., Simkova, I., Jakowitsch, J., Gabriel, H.,Baumgartner, H., Gerges, M., Celermajer, D., et al (2018).Subcutaneous treprostinil in congenital heart disease-relatedpulmonary arterial hypertension. Heart, 104(14), 1195-1199. <ahref="http://dx.doi.org/10.1136/heartjnl-2017-312143">[MoreInformation]</a>

Strange, G., Lau, E., Giannoulatou, E., Corrigan, C., Kotlyar,E., Kermeen, F., Williams, T., Celermajer, D., Dwyer, N.,Whitford, H., et al (2018). Survival of Idiopathic PulmonaryArterial Hypertension Patients in the Modern Era in Australiaand New Zealand. Heart, Lung, and Circulation, 27(11), 1368-1375. <ahref="http://dx.doi.org/10.1016/j.hlc.2017.08.018">[MoreInformation]</a>

Arnott, C., Cordina, R., Celermajer, D. (2018). TheEchocardiographic Characteristics and Prognostic Significanceof Pericardial Effusions in Eisenmenger Syndrome. Heart,Lung, and Circulation, 27(3), 394-396. <ahref="http://dx.doi.org/10.1016/j.hlc.2017.05.141">[MoreInformation]</a>

Nasir-Ahmad, S., Cordina, R., Liew, G., McCluskey, P.,Celermajer, D. (2018). The eye in CHD. Cardiology in theYoung, 28(8), 981-985. <ahref="http://dx.doi.org/10.1017/S1047951118000859">[MoreInformation]</a>

Strange, G., Celermajer, D., Marwick, T., Prior, D., Ilton, M.,Codde, J., Scalia, G., Stewart, S., Bulsara, M., Gabbay, E., et al(2018). The National Echocardiography Database Australia(NEDA): Rationale and methodology. American Heart Journal,204, 186-189. <a

href="http://dx.doi.org/10.1016/j.ahj.2018.07.001">[MoreInformation]</a>

Martinez, G., Celermajer, D., Patel, S. (2018). The NLRP3inflammasome and the emerging role of colchicine to inhibitatherosclerosis-associated inflammation. Atherosclerosis, 269,262-271. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2017.12.027">[More Information]</a>

Choteau, S., Cuesta Torres, L., Barraclough, J., Elder, A.,Martinez, G., Chen Fan, W., Shrestha, S., Ong, K., Barter, P.,Celermajer, D., et al (2018). Transcoronary gradients of HDL-associated MicroRNAs in unstable coronary artery disease.International Journal of Cardiology, 253, 138-144. <ahref="http://dx.doi.org/10.1016/j.ijcard.2017.09.190">[MoreInformation]</a>

Skoro-Sajer, N., Gerges, C., Gerges, M., Panzenbock, A.,Jakowitsch, J., Kurz, A., Taghavi, S., Sadushi-Kolici, R.,Campean, I., Klepetko, W., Celermajer, D., et al (2018).Usefulness of thrombosis and inflammation biomarkers inchronic thromboembolic pulmonary hypertension�samplingplasma and surgical specimens. Journal Of Heart And LungTransplantation, 37(9), 1067-1074. <ahref="http://dx.doi.org/10.1016/j.healun.2018.04.003">[MoreInformation]</a>

2017Indraratna, P., Alexopoulos, C., Celermajer, D., Alford, K.(2017). Acute ST-Elevation Myocardial Infarction, a UniqueComplication of Recreational Nitrous Oxide Use. Heart, Lung,and Circulation, 26(8), e41-e43. <ahref="http://dx.doi.org/10.1016/j.hlc.2017.01.019">[MoreInformation]</a>

Dennis, M., Moore, B., Kotchetkova, I., Pressley, L., Cordina,R., Celermajer, D. (2017). Adults with repaired tetralogy: Lowmortality but high morbidity up to middle age. Open Heart,4(1), 1-6. <a href="http://dx.doi.org/10.1136/openhrt-2016-000564">[More Information]</a>

Cai, T., Qasem, A., Ayer, J., Butlin, M., O'Meagher, S., Melki,C., Marks, G., Avolio, A., Celermajer, D., Skilton, M. (2017).Central blood pressure in children and adolescents: non-invasive development and testing of novel transfer functions.Journal of Human Hypertension, 31(12), 831-837. <ahref="http://dx.doi.org/10.1038/jhh.2017.59">[MoreInformation]</a>

Celermajer, D., Nasir-Ahmad, S. (2017). Cigarette smoking inAustria - a�call for action. Wiener Klinische Wochenschrift,129(23-24), 864-865. <ahref="http://dx.doi.org/10.1007/s00508-017-1254-3">[MoreInformation]</a>

Bhaskar, S., Cordato, D., Cappelen-Smith, C., Cheung, A.,Ledingham, D., Celermajer, D., Levi, C. (2017). Clarion call forhistopathological clot analysis in "cryptogenic" ischemic stroke:implications for diagnosis and treatment. Annals of Clinical andTranslational Neurology, 4(12), 926-930. <ahref="http://dx.doi.org/10.1002/acn3.500">[MoreInformation]</a>

McMullan, R., Fuller, N., Caterson, I., Celermajer, D., Gordon,A., Hespe, C., Hyett, J., O'Reilly, C., Phipps, H., Skilton, M.(2017). Developmental Origins of Health and Disease: Whoknows? Who cares? Journal of Paediatrics and Child Health,53(6), 613-614. <ahref="http://dx.doi.org/10.1111/jpc.13557">[MoreInformation]</a>

Celermajer, D. (2017). Eisenmenger syndrome: A rare maladythat continues to fascinate. European Heart Journal, 38(26),

2068-2069. <ahref="http://dx.doi.org/10.1093/eurheartj/ehx176">[MoreInformation]</a>

Cistulli, P., Celermajer, D. (2017). Endothelial Dysfunction andObstructive Sleep Apnea: The Jury Is Still Out!. AmericanJournal of Respiratory and Critical Care Medicine, 195(9),1135-1137. <a href="http://dx.doi.org/10.1164/rccm.201701-0237ED">[More Information]</a>

Lau, E., Giannoulatou, E., Celermajer, D., Humbert, M. (2017).Epidemiology and treatment of pulmonary arterialhypertension. Nature Reviews Cardiology, 14(10), 603-614. <ahref="http://dx.doi.org/10.1038/nrcardio.2017.84">[MoreInformation]</a>

Huang, L., Dalziel, K., Schilling, C., Celermajer, D., McNeil,J., Winlaw, D., Gentles, T., Radford, D., Cheung, M., Bullock,A., et al (2017). Hospital costs and cost implications of co-morbid conditions for patients with single ventricle in theperiod through to Fontan completion. International Journal ofCardiology, 240, 178-182. <ahref="http://dx.doi.org/10.1016/j.ijcard.2017.04.056">[MoreInformation]</a>

Huang, L., Schilling, C., Dalziel, K., Xie, S., Celermajer, D.,McNeil, J., Winlaw, D., Hornung, T., Radford, D., Grigg, L., etal (2017). Hospital Inpatient Costs for Single Ventricle PatientsSurviving the Fontan Procedure. American Journal ofCardiology, 120(3), 467-472. <ahref="http://dx.doi.org/10.1016/j.amjcard.2017.04.049">[MoreInformation]</a>

Moore, B., Cao, J., Kotchetkova, I., Celermajer, D. (2017).Incidence, predictors and outcomes of infective endocarditis ina contemporary adult congenital heart disease population.International Journal of Cardiology, 249, 161-165. <ahref="http://dx.doi.org/10.1016/j.ijcard.2017.08.035">[MoreInformation]</a>

Vernon, S., Coffey, S., Bhindi, R., Hoo, S., Nelson, G., Ward,M., Hansen, P., Asrress, K., Chow, C., Celermajer, D.,O'Sullivan, J., Figtree, G. (2017). Increasing proportion of STelevation myocardial infarction patients with coronaryatherosclerosis poorly explained by standard modifiable riskfactors. European Journal of Preventive Cardiology, 24(17),1824-1830. <ahref="http://dx.doi.org/10.1177/2047487317720287">[MoreInformation]</a>

Laohachai, K., Winlaw, D., Selvadurai, H., Gnanappa, G.,d�Udekem, Y., Celermajer, D., Ayer, J. (2017). Inspiratorymuscle training is associated with improved inspiratory musclestrength, resting cardiac output, and the ventilatory efficiency ofexercise in patients with a fontan circulation. Journal of theAmerican Heart Association, 6(8), 1-11. <ahref="http://dx.doi.org/10.1161/JAHA.117.005750">[MoreInformation]</a>

Liu, J., Drak, D., Krishnan, A., Chen, S., Canniffe, C., Bao, B.,Denyer, G., Celermajer, D. (2017). Left Ventricular Fibrosisand Systolic Hypertension Persist in a Repaired AorticCoarctation Model. Annals of Thoracic Surgery, 104(3), 942-949. <ahref="http://dx.doi.org/10.1016/j.athoracsur.2017.02.027">[More Information]</a>

Karam, N., Narayanana, K., Bougouin, W., Benameur, N.,Beganton, F., Jost, D., Lamhaut, L., Perier, M., Cariou, A.,Celermajer, D., et al (2017). Major Regional Differences inAutomated External Defibrillator Placement and Basic LifeSupport Training in France: Further Needs for CoordinatedImplementation. Resuscitation, 118, 49-54. <ahref="http://dx.doi.org/10.1016/j.resuscitation.2017.07.002">[More Information]</a>

Martinez, G., Barraclough, J., Nakhla, S., Kienzle, V.,Robertson, S., Mallat, Z., Celermajer, D., Patel, S. (2017).Neutrophil-derived microparticles are released into the coronarycirculation following percutaneous coronary intervention inacute coronary syndrome patients. Bioscience Reports, 37(1), 1-11. <a href="http://dx.doi.org/10.1042/BSR20160430">[MoreInformation]</a>

Ne, J., Cai, T., Celermajer, D., Caterson, I., Gill, T., Lee, C.,Skilton, M. (2017). Obesity, arterial function and arterialstructure - a systematic review and meta-analysis. ObesityScience & Practice, 3(2), 171-184. <ahref="http://dx.doi.org/10.1002/osp4.108">[MoreInformation]</a>

Moonen, A., Garsia, R., Youssef, P., Torzillo, P., Corte, T.,Boehm, C., Cordina, R., Celermajer, D., Lau, E. (2017).Outcomes of pulmonary arterial hypertension therapy inAustralia: is monotherapy adequate? Internal Medicine Journal,47(10), 1124-1128. <ahref="http://dx.doi.org/10.1111/imj.13495">[MoreInformation]</a>

Kapellas, K., Mejia, G., Bartold, P., Skilton, M., Maple-Brown,L., Slade, G., O�Dea, K., Brown, A., Celermajer, D.,Jamieson, L. (2017). Periodontal therapy and glycaemic controlamong individuals with type 2 diabetes: reflections from thePerioCardio study. International Journal of Dental Hygiene,15(4), e42-e51. <ahref="http://dx.doi.org/10.1111/idh.12234">[MoreInformation]</a>

Bougouin, W., Marijon, E., Planquette, B., Karam, N., Dumas,F., Celermajer, D., Jost, D., Lamhaut, L., Beganton, F., Cariou,A., et al (2017). Pulmonary embolism related sudden cardiacarrest admitted alive at hospital: Management and outcomes.Resuscitation, 115, 135-140. <ahref="http://dx.doi.org/10.1016/j.resuscitation.2017.04.019">[More Information]</a>

Callaghan, F., Arnott, C., Figtree, G., Kutty, S., Celermajer, D.,Grieve, S. (2017). Quantifying right atrial filling and emptying:A 4D-flow MRI study. Journal of Magnetic ResonanceImaging, 45(4), 1046-1054. <ahref="http://dx.doi.org/10.1002/jmri.25457">[MoreInformation]</a>

Callaghan, F., Arnott, C., Figtree, G., Kutty, S., Celermajer, D.,Grieve, S. (2017). Quantifying right atrial filling and emptying:A 4D-flow MRI study. Journal of Magnetic ResonanceImaging, 45(4), 1-1. <ahref="http://dx.doi.org/10.1002/jmri.25703">[MoreInformation]</a>

McKenzie, K., Dissanayake, H., McMullan, R., Caterson, I.,Celermajer, D., Gordon, A., Hyett, J., Meroni, A., Phang, M.,Raynes-Greenow, C., Polson, J., Skilton, M. (2017). Quantityand Quality of Carbohydrate Intake during Pregnancy,Newborn Body Fatness and Cardiac Autonomic Control:Conferred Cardiovascular Risk? Nutrients, 9(12), 1-12. <ahref="http://dx.doi.org/10.3390/nu9121375">[MoreInformation]</a>

Marijon, E., Celermajer, D., Jouven, X. (2017). Rheumaticheart disease � An iceberg in tropical waters. New EnglandJournal of Medicine, 377(8), 780-781. <ahref="http://dx.doi.org/10.1056/NEJMe1705840">[MoreInformation]</a>

Lau, E., Celermajer, D., Keogh, A., Thakkar, V. (2017).Screening of Pulmonary Arterial Hypertension. Seminars inRespiratory and Critical Care Medicine, 38(5), 596-605. <ahref="http://dx.doi.org/10.1055/s-0037-1606202">[MoreInformation]</a>

Barraclough, J., Garden, F., Toelle, B., O'Meagher, S., Marks,G., Cowell, C., Celermajer, D., Ayer, J. (2017). Sex differencesin aortic augmentation index in adolescents. Journal ofHypertension, 35(10), 2016-2024. <ahref="http://dx.doi.org/10.1097/HJH.0000000000001425">[More Information]</a>

Morrisroe, K., Stevens, W., Huq, M., Prior, D., Sahhar, J.,Ngian, G., Celermajer, D., Zochling, J., Proudman, S., Nikpour,M. (2017). Survival and quality of life in incident systemicsclerosis-related pulmonary arterial hypertension. ArthritisResearch and Therapy, 19(1), 1-10. <ahref="http://dx.doi.org/10.1186/s13075-017-1341-x">[MoreInformation]</a>

Gnanappa, G., Celermajer, D., Sholler, G., Gentles, T., Winlaw,D., d'Udekem, Y., Ayer, J. (2017). The Long-TermManagement of Children and Adults with a Fontan Circulation:A Systematic Review and Survey of Current Practice inAustralia and New Zealand. Pediatric Cardiology, 38, 56-69.<a href="http://dx.doi.org/10.1007/s00246-016-1484-6">[MoreInformation]</a>

Stanton, K., Ganigara, M., Corte, P., Celermajer, D., McGuire,M., Torzillo, P., Corte, T., Puranik, R. (2017). The Utility ofCardiac Magnetic Resonance Imaging in the Diagnosis ofCardiac Sarcoidosis. Heart, Lung, and Circulation, 26(11),1191-1199. <ahref="http://dx.doi.org/10.1016/j.hlc.2017.02.021">[MoreInformation]</a>

Poh, C., Zannino, D., Weintraub, R., Winlaw, D., Grigg, L.,Cordina, R., Hornung, T., Bullock, A., Justo, R., Gentles, T.,Celermajer, D., et al (2017). Three decades later: The fate of thepopulation of patients who underwent the AtriopulmonaryFontan procedure. International Journal of Cardiology, 231, 99-104. <ahref="http://dx.doi.org/10.1016/j.ijcard.2017.01.057">[MoreInformation]</a>

Skilton, M., Yeo, S., Ne, J., Celermajer, D., Caterson, I., Lee,C. (2017). Weight Loss and Carotid Intima-Media Thickness-AMeta-Analysis. Obesity, 25(2), 357-362. <ahref="http://dx.doi.org/10.1002/oby.21732">[MoreInformation]</a>

2016Krishnan, A., Drak, D., Bao, B., Celermajer, D., Liu, J. (2016).A model of early transient pressure overload simulating repairof aortic coarctation in childhood. Journal of Thoracic andCardiovascular Surgery, 151(6), 1766-1768. <ahref="http://dx.doi.org/10.1016/j.jtcvs.2016.01.048">[MoreInformation]</a>

Cai, T., Magnussen, C., Haluska, B., Johnson, D., Mottram, P.,Isbel, N., Celermajer, D., Marwick, T., Skilton, M. (2016).Carotid extra-medial thickness does not predict adversecardiovascular outcomes in high-risk adults. Diabetes andMetabolism, 42(3), 200-203. <ahref="http://dx.doi.org/10.1016/j.diabet.2015.12.001">[MoreInformation]</a>

Cai, T., Sullivan, T., Ayer, J., Harmer, J., Leeder, S., Toelle, B.,Marks, G., Celermajer, D., Skilton, M. (2016). Carotidextramedial thickness is associated with local arterial stiffnessin children. Journal of Hypertension, 34(1), 109-115. <ahref="http://dx.doi.org/10.1097/HJH.0000000000000769">[More Information]</a>

Robertson, S., Martinez, G., Payet, C., Barraclough, J.,Celermajer, D., Bursill, C., Patel, S. (2016). Colchicine Therapyin Acute Coronary Syndrome Patients acts on Caspase-1 toSuppress NLRP3 Inflammasome Monocyte Activation. Clinical

Science, 130(14), 1237-1246. <ahref="http://dx.doi.org/10.1042/CS20160090">[MoreInformation]</a>

Celermajer, D., Strange, G., Cordina, R., Selbie, L., Sholler, G.,Winlaw, D., Alphonso, N., Justo, R., Nicholae, M., Kasparian,N., et al (2016). Congenital Heart Disease Requires a LifetimeContinuum of Care: A call for a Regional Registry. Heart,Lung, and Circulation, 25(8), 750-754. <ahref="http://dx.doi.org/10.1016/j.hlc.2016.03.018">[MoreInformation]</a>

Offen, S., Jackson, D., Canniffe, C., Choudhary, P., Celermajer,D. (2016). Dextrocardia in Adults with Congenital HeartDisease. Heart, Lung, and Circulation, 25(4), 352-357. <ahref="http://dx.doi.org/10.1016/j.hlc.2015.09.003">[MoreInformation]</a>

Kizirian, N., Kong, Y., Muirhead, R., Brodie, S., Garnett, S.,Petocz, P., Sim, K., Celermajer, D., Louie, J., Markovic, T.,Ross, G., Brand-Miller, J., Skilton, M., et al (2016). Effects of alow-glycemic index diet during pregnancy on offspring growth,body composition, and vascular health: A pilot randomizedcontrolled trial. American Journal of Clinical Nutrition, 103(4),1073-1082. <ahref="http://dx.doi.org/10.3945/ajcn.115.123695">[MoreInformation]</a>

Chia, E., Lau, E., Xuan, W., Celermajer, D., Thomas, L. (2016).Exercise testing can unmask right ventricular dysfunction insystemic sclerosis patients with normal resting pulmonaryartery pressure. International Journal of Cardiology, 204, 179-186. <ahref="http://dx.doi.org/10.1016/j.ijcard.2015.11.186">[MoreInformation]</a>

Bougouin, W., Marijon, E., Planquette, B., Karam, N., Dumas,F., Celermajer, D., Jost, D., Lamhaut, L., Beganton, F., Cariou,A., et al (2016). Factors Associated With Pulmonary Embolism-Related Sudden Cardiac Arrest. Circulation, 134(25), 2125-2127. <ahref="http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024746">[More Information]</a>

Amarasena, N., Kapellas, K., Skilton, M., Maple-Brown, L.,Brown, A., Bartold, M., O'Dea, K., Celermajer, D., Jamieson,L. (2016). Factors associated with routine dental attendanceamong aboriginal Australians. Journal of Health Care for thePoor and Underserved, 27(1), 67-80. <ahref="http://dx.doi.org/10.1353/hpu.2016.0040">[MoreInformation]</a>

Wright, L., Dwyer, N., Celermajer, D., Kritharides, L.,Marwick, T. (2016). Follow-Up of Pulmonary HypertensionWith Echocardiography. JACC: Cardiovascular Imaging, 9(6),733-746. <ahref="http://dx.doi.org/10.1016/j.jcmg.2016.02.022">[MoreInformation]</a>

Tan, J., Prosser, H., Dunn, L., Vanags, L., Ridiandries, A.,Tsatralis, T., Leece, L., Clayton, Z., Yuen, S., Robertson, S.,Lam, M., Celermajer, D., Ng, M., Bursill, C. (2016). HighDensity Lipoproteins Rescue Diabetes-Impaired Angiogenesisvia Scavenger Receptor Class B Type I. Diabetes, 65(10), 3091-3103. <a href="http://dx.doi.org/10.2337/db15-1668">[MoreInformation]</a>

Kapadia, R., Choudhary, P., Collins, N., Celermajer, D.,Puranik, R. (2016). Left Ventricular Non-compaction in Holt-Oram Syndrome. Heart, Lung, and Circulation, 25(6), 626-630.<a href="http://dx.doi.org/10.1016/j.hlc.2015.12.098">[MoreInformation]</a>

Nikpour, M., Prior, D., Celermajer, D. (2016). Letter byNikpour et al regarding article, "Effect of warfarin treatment on

survival of patients with Pulmonary Arterial Hypertension(PAH) in the Registry to Evaluate Early and Long-Term PAHDisease Management (REVEAL)". Circulation, 133(20). <ahref="http://dx.doi.org/10.1161/CIRCULATIONAHA.116.021847">[More Information]</a>

Cairns, T., Shi, W., Iyengar, A., Nisbet, A., Forsdick, V.,Zannino, D., Gentles, T., Radford, D., Justo, R., Celermajer, D.,Winlaw, D., et al (2016). Long-term outcomes after first-onsetarrhythmia in Fontan physiology. Journal of Thoracic andCardiovascular Surgery, 152(5), 1355-1363.e1. <ahref="http://dx.doi.org/10.1016/j.jtcvs.2016.07.073">[MoreInformation]</a>

Lau, E., Chemla, D., Godinas, L., Zhu, K., Sitbon, O., Savale,L., Montani, D., Jais, X., Celermajer, D., Simonneau, G., et al(2016). Loss of Vascular Distensibility During Exercise is anEarly Hemodynamic Marker of Pulmonary Vascular Disease.Chest, 149(2), 353-361. <ahref="http://dx.doi.org/10.1378/chest.15-0125">[MoreInformation]</a>

Clift, P., Celermajer, D. (2016). Managing adult Fontanpatients: where do we stand? European Respiratory Review,25(142), 438-450. <ahref="http://dx.doi.org/10.1183/16000617.0091-2016">[MoreInformation]</a>

Calderone, A., Stevens, W., Prior, D., Nandurkar, H., Gabbay,E., Proudman, S., Williams, T., Celermajer, D., Sahhar, J.,Wong, P., et al (2016). Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban insystemic sclerosis-related pulmonary arterial hypertension: theSPHInX study protocol. BMJ Open, 6(12), 1-12. <ahref="http://dx.doi.org/10.1136/bmjopen-2016-011028">[MoreInformation]</a>

Neubeck, A., Gallagher, R., Ingram, K., Celermajer, D.,Schumacher, T., Ferry, K., Buckley, T., Redfern, J., Chow, C.,Tofler, G., Figtree, G. (2016). MyHeartMate: Development of aDigital Game to Improve Secondary Prevention ofCardiovascular Disease. Abstracts for the 64th Cardiac Societyof Australia and New Zealand Annual Scientific Meeting andthe International Society for Heart Research AustralasianSection Annual Scientific Meeting, Adelaide: Elsevier.

Iyengar, A., Winlaw, D., Galati, J., Wheaton, G., Gentles, T.,Grigg, L., Justo, R., Radford, D., Attard, C., Weintraub, R.,Sholler, G., Celermajer, D., et al (2016). No difference betweenaspirin and warfarin after extracardiac Fontan in a propensityscore analysis of 475 patients. European Journal Of Cardio-Thoracic Surgery, 50(5), 980-987. <ahref="http://dx.doi.org/10.1093/ejcts/ezw159">[MoreInformation]</a>

Hansen, T., Galougahi, K., Celermajer, D., Rasko, N., Tang, O.,Bubb, K., Figtree, G. (2016). Oxidative and NitrosativeSignalling in Pulmonary Arterial Hypertension- Implicationsfor Development of Novel Therapies. Pharmacology &Therapeutics, 165, 50-62. <ahref="http://dx.doi.org/10.1016/j.pharmthera.2016.05.005">[More Information]</a>

Seneviratne, M., Grieve, S., Figtree, G., Garsia, R., Celermajer,D., Adelstein, S., Puranik, R. (2016). Prevalence, distributionand clinical correlates of myocardial fibrosis in systemic lupuserythematosus: a cardiac magnetic resonance study. Lupus,25(6), 573-581. <ahref="http://dx.doi.org/10.1177/0961203315622275">[MoreInformation]</a>

Lau, E., Godinas, L., Sitbon, O., Montani, D., Savale, L., Jais,X., Lador, F., Gunther, S., Celermajer, D., Simonneau, G., et al(2016). Resting pulmonary artery pressure of 21-24 mmHgpredicts abnormal exercise haemodynamics. European

Respiratory Journal, 47(5), 1436-1444. <ahref="http://dx.doi.org/10.1183/13993003.01684-2015">[MoreInformation]</a>

Wright, L., Dwyer, N., Power, J., Kritharides, L., Celermajer,D., Marwick, T. (2016). Right Ventricular Systolic FunctionResponses to Acute and Chronic Pulmonary Hypertension:Assessment with Myocardial Deformation. Journal of theAmerican Society of Echocardiography, 29(3), 259-266. <ahref="http://dx.doi.org/10.1016/j.echo.2015.11.010">[MoreInformation]</a>

Kutty, S., Rathod, R., Danford, D., Celermajer, D. (2016). Roleof imaging in the evaluation of single ventricle with the Fontanpalliation. Heart, 102(3), 174-183. <ahref="http://dx.doi.org/10.1136/heartjnl-2015-308298">[MoreInformation]</a>

Choudhary, P., Nandakumar, R., Greig, H., Broadhurst, P.,Dean, J., Puranik, R., Celermajer, D., Hillis, G. (2016).Structural and electrical cardiac abnormalities are prevalent inasymptomatic adults with myotonic dystrophy. Heart, 102(18),1472-1478. <a href="http://dx.doi.org/10.1136/heartjnl-2015-308517">[More Information]</a>

McCombe, A., Touma, F., Jackson, D., Canniffe, C.,Choudhary, P., Pressley, L., Tanous, D., Robinson, P.,Celermajer, D. (2016). Sudden cardiac death in adults withcongenitally corrected transposition of the great arteries. OpenHeart, 3(2), 1-7. <a href="http://dx.doi.org/10.1136/openhrt-2016-000407">[More Information]</a>

Arnott, C., Boehm, C., Lau, E., Celermajer, D. (2016). Survivaloutcomes in severe congenital versus non-congenital pulmonaryhypertension. Heart Asia, 8(1), 3-7. <ahref="http://dx.doi.org/10.1136/heartasia-2015-010702">[MoreInformation]</a>

Skilton, M., Nakhla, S., Ayer, J., Harmer, J., Toelle, B., Leeder,S., Jones, G., Marks, G., Celermajer, D. (2016). Telomerelength in early childhood: Early life risk factors and associationwith carotid intima-media thickness in later childhood.European Journal of Preventive Cardiology, 23(10), 1086-1092. <ahref="http://dx.doi.org/10.1177/2047487315607075">[MoreInformation]</a>

Poh, C., Cochrane, A., Galati, J., Bullock, A., Celermajer, D.,Gentles, T., du Plessis, K., Winlaw, D., Hornung, T., Finucane,K., et al (2016). Ten-year outcomes of Fontan conversion inAustralia and New Zealand demonstrate the superiority of astrategy of early conversion. European Journal Of Cardio-Thoracic Surgery, 49(2), 530-535. <ahref="http://dx.doi.org/10.1093/ejcts/ezv112">[MoreInformation]</a>

Brown, R., Celermajer, D., Macefield, V., Sander, M. (2016).The Effect of Nitric Oxide Inhibition in Spinal Cord InjuredHumans with and without Preserved Sympathetic Control of theVasculature. Frontiers in Neuroscience, 10, 1-8. <ahref="http://dx.doi.org/10.3389/fnins.2016.00095">[MoreInformation]</a>

Schilling, C., Dalziel, K., Nunn, R., du Plessis, K., Shi, W.,Celermajer, D., Winlaw, D., Weintraub, R., Grigg, L., Radford,D., et al (2016). The Fontan epidemic: Population projectionsfrom the Australia and New Zealand Fontan Registry.International Journal of Cardiology, 219, 14-19. <ahref="http://dx.doi.org/10.1016/j.ijcard.2016.05.035">[MoreInformation]</a>

Grimaldi, A., Mocumbi, A., Freers, J., Lachaud, M., Mirabel,M., Ferreira, B., Narayanan, K., Celermajer, D., Sidi, D.,Jouven, X., et al (2016). Tropical Endomyocardial Fibrosis:Natural History, Challenges, and Perspectives. Circulation,

133(24), 2503-2515. <ahref="http://dx.doi.org/10.1161/CIRCULATIONAHA.115.021178">[More Information]</a>

Wilson, T., Iyengar, A., Winlaw, D., Weintraub, R., Wheaton,G., Gentles, T., Ayer, J., Grigg, L., Justo, R., Radford, D.,Celermajer, D., et al (2016). Use of ACE inhibitors in Fontan:Rational or irrational? International Journal of Cardiology,210, 95-99. <ahref="http://dx.doi.org/10.1016/j.ijcard.2016.02.089">[MoreInformation]</a>

Callaghan, F., Kozor, R., Sherrah, A., Vallely, M., Celermajer,D., Figtree, G., Grieve, S. (2016). Use of multi-velocityencoding 4D flow MRI to improve quantification of flowpatterns in the aorta. Journal of Magnetic Resonance Imaging,43(2), 352-363. <ahref="http://dx.doi.org/10.1002/jmri.24991">[MoreInformation]</a>

Iyengar, A., Celermajer, D., Winlaw, D., d'Udekem, Y. (2016).Young and Free: Over 25 Years of Seminal Contributions toComplex Congenital Heart Disease From Australia & NewZealand. Heart, Lung, and Circulation, 25(6), 529-534. <ahref="http://dx.doi.org/10.1016/j.hlc.2016.03.001">[MoreInformation]</a>

2015Strange, G., Rose, M., Kermeen, F., O'Donnell, C., Keogh, A.,Kotlyar, E., Grigg, L., Bullock, A., Disney, P., Dwyer, N.,Celermajer, D., et al (2015). A binational registry of adults withpulmonary arterial hypertension complicating congenital heartdisease. Internal Medicine Journal, 45(9), 944-950. <ahref="http://dx.doi.org/10.1111/imj.12821">[MoreInformation]</a>

Jogia, D., Liang, M., Lin, Z., Celermajer, D. (2015). A PotentialEchocardiographic Classification for Constrictive PericarditisBased on Analysis of Abnormal Septal Motion. Journal ofcardiovascular ultrasound, 23(3), 143-149. <ahref="http://dx.doi.org/10.4250/jcu.2015.23.3.143">[MoreInformation]</a>

Amarasena, N., Kapellas, K., Skilton, M., Maple-Brown, L.,Brown, A., O’Dea, K., Celermajer, D., Jamieson, L. (2015).Associations with dental caries experience among aconvenience sample of Aboriginal Australian adults. AustralianDental Journal, 60(4), 471-478. <ahref="http://dx.doi.org/10.1111/adj.12256">[MoreInformation]</a>

Yu, Y., Wise, S., Celermajer, D., Bilek, M., Ng, M. (2015).Bioengineering stents with proactive biocompatibility.Interventional Cardiology, 7(6), 571-584. <ahref="http://dx.doi.org/10.2217/ica.15.46">[MoreInformation]</a>

Yu, Y., Wise, S., Michael, P., Bax, D., Yuen, G., Hiob, M.,Yeo, G., Filipe, E., Dunn, L., Chan, K., Mollahajian, H.,Celermajer, D., Weiss, A., Ng, M. (2015). Characterization ofEndothelial Progenitor Cell Interactions with HumanTropoelastin. PloS One, 10(6), 1-16. <ahref="http://dx.doi.org/10.1371/journal.pone.0131101">[MoreInformation]</a>

Martinez, G., Robertson, S., Barraclough, J., Xia, Q., Mallat, Z.,Bursill, C., Celermajer, D., Patel, S. (2015). Colchicine AcutelySuppresses Local Cardiac Production of InflammatoryCytokines in Patients With an Acute Coronary Syndrome.Journal of the American Heart Association, 4(8), 1-10. <ahref="http://dx.doi.org/10.1161/JAHA.115.002128">[MoreInformation]</a>

Sharma, T., Lau, E., Choudhary, P., Torzillo, P., Munoz, P.,

Simmons, L., Naeije, R., Celermajer, D. (2015). Dobutaminestress for evaluation of right ventricular reserve in pulmonaryarterial hypertension. European Respiratory Journal, 45(3),700-708. <ahref="http://dx.doi.org/10.1183/09031936.00089914">[MoreInformation]</a>

Lau, E., Humbert, M., Celermajer, D. (2015). Early detection ofpulmonary arterial hypertension. Nature Reviews Cardiology,12(3), 143-155. <ahref="http://dx.doi.org/10.1038/nrcardio.2014.191">[MoreInformation]</a>

Luu, Q., Choudhary, P., Jackson, D., Canniffe, C., McGuire,M., Chard, R., Celermajer, D. (2015). Ebstein's Anomaly inThose Surviving to Adult Life - A Single Centre Experience.Heart, Lung, and Circulation, 24(10), 996-1001. <ahref="http://dx.doi.org/10.1016/j.hlc.2015.03.016">[MoreInformation]</a>

Padang, R., Ganigara, M., O'Meagher, S., Grieve, S., Bannon,P., Celermajer, D., Jeremy, R., Semsarian, C., Puranik, R.(2015). Feasibility of using real-time CMR imaging to evaluateacute thoracic aortic response to exercise. International Journalof Cardiology, 197, 306-308. <ahref="http://dx.doi.org/10.1016/j.ijcard.2015.05.187">[MoreInformation]</a>

Harmer, J., Keech, A., Veillard, A., Skilton, M., Marwick, T.,Watts, G., Meredith, I., Celermajer, D. (2015). Fenofibrateeffects on arterial endothelial function in adults with type 2diabetes mellitus: A FIELD substudy. Atherosclerosis, 242(1),295-302. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2015.07.038">[More Information]</a>

Bougouin, W., Mustafic, H., Marijon, E., Murad, M., Dumas,F., Barbouttis, A., Jabre, P., Beganton, F., Empana, J.,Celermajer, D., et al (2015). Gender and survival after suddencardiac arrest: A systematic review and meta-analysis.Resuscitation, 94, 55-60. <ahref="http://dx.doi.org/10.1016/j.resuscitation.2015.06.018">[More Information]</a>

Choudhary, P., Hsu, C., Grieve, S., Smillie, C., Singarayar, S.,Semsarian, C., Richmond, D., Muthurangu, V., Celermajer, D.,Puranik, R. (2015). Improving the diagnosis of LV non-compaction with cardiac magnetic resonance imaging.International Journal of Cardiology, 181, 430-436. <ahref="http://dx.doi.org/10.1016/j.ijcard.2014.12.053">[MoreInformation]</a>

Choudhary, P., Canniffe, C., Jackson, D., Tanous, D., Walsh,K., Celermajer, D. (2015). Late outcomes in adults withcoarctation of the aorta. Heart, 101(15), 1190-1195. <ahref="http://dx.doi.org/10.1136/heartjnl-2014-307035">[MoreInformation]</a>

Ayer, J., Charakida, M., Deanfield, J., Celermajer, D. (2015).Lifetime risk: childhood obesity and cardiovascular risk.European Heart Journal, 36(22), 1371-1376. <ahref="http://dx.doi.org/10.1093/eurheartj/ehv089">[MoreInformation]</a>

Cordina, R., Leaney, J., Golzan, S., Grieve, S., Celermajer, D.,Graham, S. (2015). Ophthalmological consequences of cyanoticcongenital heart disease: vascular parameters and nerve fibrelayer. Clinical and Experimental Ophthalmology, 43(2), 115-123. <a href="http://dx.doi.org/10.1111/ceo.12401">[MoreInformation]</a>

Fulcher, J., Patel, S., Nicholls, S., Bao, B., Celermajer, D.(2015). Optical coherence tomography for serial in vivoimaging of aortic plaque in the rabbit: a preliminary experience.Open Heart, 2(1), 1-8. <a

href="http://dx.doi.org/10.1136/openhrt-2015-000314">[MoreInformation]</a>

Mirabel, M., Celermajer, D., Beraud, A., Jouven, X., Marijon,E., Hagege, A. (2015). Pocket-sized focused cardiac ultrasound:strengths and limitations. Archives of Cardiovascular Diseases,108(3), 197-205. <ahref="http://dx.doi.org/10.1016/j.acvd.2015.01.002">[MoreInformation]</a>

Marijon, E., Bougouin, W., Tafflet, M., Karam, N., Jost, D.,Lamhaut, L., Beganton, F., Pelloux, P., Degrange, H.,Celermajer, D., et al (2015). Population movement and suddencardiac arrest location. Circulation, 131(18), 1546-1554. <ahref="http://dx.doi.org/10.1161/CIRCULATIONAHA.114.010498">[More Information]</a>

Amarasena, N., Kapellas, K., Brown, A., Skilton, M., Maple-Brown, L., Bartold, P., O'Dea, K., Celermajer, D., Slade, G.,Jamieson, L. (2015). Psychological distress and self-rated oralhealth among a convenience sample of Indigenous Australians.Journal of Public Health Dentistry, 75(2), 126-133. <ahref="http://dx.doi.org/10.1111/jphd.12080">[MoreInformation]</a>

O'Meagher, S., Seneviratne, M., Skilton, M., Munoz, P.,Robinson, P., Malitz, N., Tanous, D., Celermajer, D., Puranik,R. (2015). Right Ventricular Mass is Associated with ExerciseCapacity in Adults with Repaired Tetralogy of Fallot. PediatricCardiology, 36(6), 1225-1131. <ahref="http://dx.doi.org/10.1007/s00246-015-1150-4">[MoreInformation]</a>

Arnott, C., Skilton, M., Ruohonen, S., Juonala, M., Viikari, J.,Kahönen, M., Lehtimaki, T., Laitinen, T., Celermajer, D.,Raitakari, O. (2015). Subtle increases in heart size persist intoadulthood in growth restricted babies: the Cardiovascular Riskin Young Finns Study. Open Heart, 2(1), 1-9. <ahref="http://dx.doi.org/10.1136/openhrt-2015-000265">[MoreInformation]</a>

Marijon, E., Bougouin, W., Karam, N., Beganton, F., Lamhaut,L., Perier, M., Benameur, N., Tafflet, M., Beal, G., Hagege, A.,Celermajer, D., et al (2015). Survival from sports-relatedsudden cardiac arrest: In sports facilities versus outside ofsports facilities. American Heart Journal, 170(2), 339-345.e1.<a href="http://dx.doi.org/10.1016/j.ahj.2015.03.022">[MoreInformation]</a>

Skilton, M., Pahkala, K., Viikari, J., Ronnemaa, T., Simell, O.,Jula, A., Niinikoski, H., Celermajer, D., Raitakari, O. (2015).The association of dietary alpha-linolenic Acid with bloodpressure and subclinical atherosclerosis in people born small forgestational age: the special turku coronary risk factorintervention project study. The Journal of Pediatrics, 166(5),1252-1257.e2. <ahref="http://dx.doi.org/10.1016/j.jpeds.2015.01.020">[MoreInformation]</a>

Lau, E., Celermajer, D., Naeije, R. (2015). The emerging role ofthe contractile and vascular reserves in pulmonary arterialhypertension. European Respiratory Journal, 45(6), 1758-1759.<ahref="http://dx.doi.org/10.1183/09031936.00027115">[MoreInformation]</a>

Forsdick, V., Iyengar, A., Cairns, T., Gentles, T., Weintraub,R., Celermajer, D., d'Udekem, Y. (2015). Unsatisfactory Earlyand Late Outcomes After Fontan Surgery Delayed toAdolescence and Adulthood. Seminars in Thoracic andCardiovascular Surgery, 27(2), 168-174. <ahref="http://dx.doi.org/10.1053/j.semtcvs.2015.05.001">[MoreInformation]</a>

Cordina, R., Nakhla, S., O'Meagher, S., Leaney, J., Graham, S.,

Celermajer, D. (2015). Widespread endotheliopathy in adultswith cyanotic congenital heart disease. Cardiology in theYoung, 25(3), 511-519. <ahref="http://dx.doi.org/10.1017/S1047951114000262">[MoreInformation]</a>

2014Dunn, L., Simpson, P., Prosser, H., Lecce (Venuto), L., Yuen,S., Buckle, A., Sieveking, D., Vanags, L., Lim, P., Chow, R.,Bao, B., Davies, M., Celermajer, D., Bursill, C., Ng, M., et al(2014). A Critical Role for Thioredoxin Interacting Protein inDiabetes-Related Impairment of Angiogenesis. Diabetes, 63(2),675-687. <a href="http://dx.doi.org/10.2337/db13-0417">[More Information]</a>

Martinez, G., Bailey, B., Celermajer, D., Patel, S. (2014). Asafe and easy technique to sample the coronary sinus -Facilitating a closer look at cardiac disease. InternationalJournal of Cardiology, 176(3), 1321-1322. <ahref="http://dx.doi.org/10.1016/j.ijcard.2014.07.151">[MoreInformation]</a>

Ganigara, M., Collins, N., Tanous, D., Celermajer, D., Puranik,R. (2014). Anomalous left anterior descending coronary arteryfrom the pulmonary artery - The role of cardiac MRI.International Journal of Cardiology, 172(1), e172-e174. <ahref="http://dx.doi.org/10.1016/j.ijcard.2013.12.056">[MoreInformation]</a>

Lau, E., Abelson, D., Dwyer, N., Yu, Y., Ng, M., Celermajer,D. (2014). Assessment of ventriculo-arterial interaction inpulmonary arterial hypertension using wave intensity analysis.European Respiratory Journal, 43(6), 1804-1807. <ahref="http://dx.doi.org/10.1183/09031936.00148313">[MoreInformation]</a>

Kapellas, K., Jamieson, L., Do, L., Bartold, P., Wang, H.,Maple-Brown, L., Sullivan, D., O'Dea, K., Brown, A.,Celermajer, D., Skilton, M., et al (2014). Associations betweenperiodontal disease and cardiovascular surrogate measuresamong Indigenous Australians. International Journal ofCardiology, 173(2), 190-196. <ahref="http://dx.doi.org/10.1016/j.ijcard.2014.02.015">[MoreInformation]</a>

Chow, V., Yeoh, T., Ng, A., Pasqualon, T., Scott, E., Plater, J.,Whitwell, B., Hanzek, D., Chung, T., Thomas, L., Celermajer,D., Kritharides, L. (2014). Asymptomatic left ventriculardysfunction with long-term clozapine treatment forschizophrenia:a multicentre cross-sectional cohort study. OpenHeart, 1, 1-10. <a href="http://dx.doi.org/10.1136/openhrt-2013-000030">[More Information]</a>

Cordina, R., Grieve, S., Barnett, M., Lagopoulos, J., Malitz, N.,Celermajer, D. (2014). Brain volumetric, regional corticalthickness and radiographic findings in adults with cyanoticcongenital heart disease. NeuroImage: Clinical, 4, 319-325. <ahref="http://dx.doi.org/10.1016/j.nicl.2013.12.011">[MoreInformation]</a>

Sim, L., Semsarian, C., Celermajer, D., Puranik, R. (2014).Cardiac Amyloidosis:The Role of Magnetic ResonanceImaging. Open Journal of Clinical Diagnostics, 4, 27-30. <ahref="http://dx.doi.org/10.4236/ojcd.2014.41006">[MoreInformation]</a>

Harmer, J., Keech, A., Veillard, A., Skilton, M., Marwick, T.,Watts, G., Meredith, I., Celermajer, D. (2014). Cigarettesmoking and albuminuria are associated with impaired arterialsmooth muscle function in patients with type 2 diabetesmellitus: a FIELD substudy. Diabetes Research and ClinicalPractice, 106(2), 328-336. <ahref="http://dx.doi.org/10.1016/j.diabres.2014.08.029">[MoreInformation]</a>

Szopos, M., Poussineau, N., Maday, Y., Canniffe, C.,Celermajer, D., Bonnet, D., Ou, P. (2014). Computationalmodeling of blood flow in the aorta - insights into eccentric dilatation of the ascending aorta after surgery for coarctation. Journal of Thoracic and CardiovascularSurgery, 148(4), 1572-1582. <ahref="http://dx.doi.org/10.1016/j.jtcvs.2013.11.055">[MoreInformation]</a>

Padang, R., Dennis, M., Semsarian, C., Bannon, P., Tanous, D.,Celermajer, D., Puranik, R. (2014). Detection of SeriousComplications by MR Imaging in Asymptomatic Young Adultswith Repaired Coarctation of the Aorta. Heart, Lung, andCirculation, 23(4), 332-338. <ahref="http://dx.doi.org/10.1016/j.hlc.2013.10.055">[MoreInformation]</a>

Lau, E., Vanderpool, R., Choudhary, P., Simmons, L., Corte,T., Argiento, P., DAlto, M., Naeije, R., Celermajer, D. (2014).Dobutamine Stress Echocardiography for the Assessment ofPressure-Flow Relationships of the Pulmonary Circulation.Chest, 146(4), 959-966. <ahref="http://dx.doi.org/10.1378/chest.13-2300">[MoreInformation]</a>

Kapellas, K., Maple-Brown, L., Jamieson, L., Do, L., O'Dea,K., Brown, A., Cai, T., Anstey, N., Sullivan, D., Wang, H.,Celermajer, D., Skilton, M., et al (2014). Effect of PeriodontalTherapy on Arterial Structure and Function Among AboriginalAustralians: A Randomized, Controlled Trial. Hypertension,64(4), 702-708. <ahref="http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.03359">[More Information]</a>

Skilton, M., Siitonen, N., Wurtz, P., Viikari, J., Juonala, M.,Seppala, I., Laitinen, T., Lehtimaki, T., Taittonen, L., Kahonen,M., Celermajer, D., et al (2014). High birth weight is associatedwith obesity and increased carotid wall thickness in youngadults: the cardiovascular risk in young Finns study.Arteriosclerosis, Thrombosis, and Vascular Biology, 34(5),1064-1068. <ahref="http://dx.doi.org/10.1161/ATVBAHA.113.302934">[More Information]</a>

McGrath, K., Li, X., Whitworth, P., Kasz, R., Tan, J.,McLennan, S., Celermajer, D., Barter, P., Rye, K., Heather, A.(2014). High density lipoproteins improve insulin sensitivity inhigh-fat diet-fed mice by suppressing hepatic inflammation.Journal of Lipid Research, 55(3), 421-430. <ahref="http://dx.doi.org/10.1194/jlr.M043281">[MoreInformation]</a>

Nayyar, D., Muthiah, K., Kumarasinghe, G., Hettiarachchi, R.,Celermajer, D., Kotlyar, E., Keogh, A. (2014). Imatinib for thetreatment of pulmonary arterial hypertension and pulmonarycapillary hemangiomatosis. Pulmonary Circulation, 4(2), 342-345.

Chow, V., Ng, A., Seccombe, L., Chung, T., Thomas, L.,Celermajer, D., Peters, M., Kritharides, L. (2014). Impaired 6-min walk test, heart rate recovery and cardiac function postpulmonary embolism in long-term survivors. RespiratoryMedicine, 108(10), 1556-1565. <ahref="http://dx.doi.org/10.1016/j.rmed.2014.08.002">[MoreInformation]</a>

Bouzeman, A., Marijon, E., De Guillebon, M., Ladouceu, M.,Duthoit, G., Amet, D., Martins, R., Otmani, A., Lavergne, T.,Bordachar, P., Celermajer, D., et al (2014). Implantable cardiacdefibrillator among adults with transposition of the greatarteries and atrial switch operation: Case series and review ofliterature. International Journal of Cardiology, 177(1), 301-306. <a

href="http://dx.doi.org/10.1016/j.ijcard.2014.09.015">[MoreInformation]</a>

Bougouin, W., Marijon, E., Puymirat, E., Defaye, P.,Celermajer, D., Le Heuzey, J., Bovéda, S., Kacet, S., Mabo, P.,Barnay, C., et al (2014). Incidence of sudden cardiac death afterventricular fibrillation complicating acute myocardialinfarction: a 5-year cause-of-death analysis of the FAST-MI2005 registry. European Heart Journal, 35(2), 116-122. <ahref="http://dx.doi.org/10.1093/eurheartj/eht453">[MoreInformation]</a>

Martinez, G., Seco, M., Jaijee, S., Adams, M., Cartwright, B.,Forrest, P., Celermajer, D., Vallely, M., Wilson, M., Ng, M.(2014). Introduction of an Interdisciplinary Heart Team-basedTranscatheter Aortic Valve Implantation Programme: Short andMid-term Outcomes. Internal Medicine Journal, 44(9), 876-883. <a href="http://dx.doi.org/10.1111/imj.12514">[MoreInformation]</a>

Dennis, M., Laarkson, M., Padang, R., Tanous, D., Robinson,P., Pressley, L., O'Meagher, S., Celermajer, D., Puranik, R.(2014). Long term followup of aortic root size after repair oftetralogy of Fallot. International Journal of Cardiology, 177(1),136-138. <ahref="http://dx.doi.org/10.1016/j.ijcard.2014.09.113">[MoreInformation]</a>

O'Meagher, S., Munoz, P., Muthurangu, V., Robinson, P.,Malitz, N., Tanous, D., Celermajer, D., Puranik, R. (2014).Mechanisms of maintained exercise capacity in adults withrepaired tetralogy of Fallot. International Journal ofCardiology, 177(1), 178-181. <ahref="http://dx.doi.org/10.1016/j.ijcard.2014.09.008">[MoreInformation]</a>

Amarasena, N., Kapellas, K., Skilton, M., Maple-Brown, L.,Brown, A., Bartold, P., O'Dea, K., Celermajer, D., Slade, G.,Jamieson, L. (2014). Oral health behaviours and perceptionsreported by Indigenous Australians living in Darwin, NorthernTerritory. Community Dental Health, 31(1), 57-61. <ahref="http://dx.doi.org/10.1922/CDH_3276Jamieson05">[MoreInformation]</a>

Kapellas, K., Skilton, M., Maple-Brown, L., Do, L., Bartold, P.,O'Dea, K., Brown, A., Celermajer, D., Jamieson, L. (2014).Periodontal disease and dental caries among IndigenousAustralians living in the Northern Territory, Australia.Australian Dental Journal, 59(1), 93-99. <ahref="http://dx.doi.org/10.1111/adj.12135">[MoreInformation]</a>

O'Meagher, S., Ganigara, M., Tanous, D., Celermajer, D.,Puranik, R. (2014). Progress of right ventricular dilatation inadults with repaired tetralogy of Fallot and free pulmonaryregurgitation. IJC Heart & Vessels, 3, 28-31. <ahref="http://dx.doi.org/10.1016/j.ijchv.2014.02.003">[MoreInformation]</a>

Lau, E., Celermajer, D. (2014). Protecting our children fromenvironmental tobacco smoke: one of our great healthcarechallenges. European Heart Journal, 35(36), 2452-2453. <ahref="http://dx.doi.org/10.1093/eurheartj/ehu098">[MoreInformation]</a>

Lau, E., Bailey, D., Bailey, E., Torzillo, P., Roach, P.,Schembri, G., Corte, T., Celermajer, D. (2014). Pulmonaryhypertension leads to a loss of gravity dependent redistributionof regional lung perfusion: a SPECT/CT study. Heart, 100(1),47-53. <a href="http://dx.doi.org/10.1136/heartjnl-2013-304254">[More Information]</a>

d'Udekem, Y., Iyengar, A., Galati, J., Forsdick, V., Weintraub,R., Wheaton, G., Bullock, A., Justo, R., Grigg, L., Sholler, G.,Celermajer, D., Winlaw, D., et al (2014). Redefining

expectations of long-term survival after the Fontan procedure:twenty-five years of follow-up from the entire population ofAustralia and New Zealand. Circulation, 130(11), S32-S38. <ahref="http://dx.doi.org/10.1161/CIRCULATIONAHA.113.007764">[More Information]</a>

O'Meagher, S., Ganigara, M., Munoz, P., Tanous, D., Chard,R., Celermajer, D., Puranik, R. (2014). Right VentricularOutflow Tract Enlargement Prior to Pulmonary ValveReplacement is Associated with Poorer Structural andFunctional Outcomes, in Adults with Repaired Tetralogy ofFallot. Heart, Lung, and Circulation, 23(5), 482-488. <ahref="http://dx.doi.org/10.1016/j.hlc.2013.11.009">[MoreInformation]</a>

Iyengar, A., Winlaw, D., Galati, J., Gentles, T., Weintraub, R.,Justo, R., Wheaton, G., Bullock, A., Celermajer, D., d'Udekem,Y. (2014). The Australia and New Zealand Fontan Registry:description and initial results from the first population-basedFontan registry. Internal Medicine Journal, 44(2), 148-155. <ahref="http://dx.doi.org/10.1111/imj.12318">[MoreInformation]</a>

Iyengar, A., Winlaw, D., Galati, J., Wheaton, G., Gentles, T.,Grigg, L., Justo, R., Radford, D., Weintraub, R., Bullock, A.,Celermajer, D., et al (2014). The extracardiac conduit Fontanprocedure in Australia and New Zealand: hypoplastic left heartsyndrome predicts worse early and late outcomes. EuropeanJournal Of Cardio-Thoracic Surgery, 46(3), 465-473. <ahref="http://dx.doi.org/10.1093/ejcts/ezu015">[MoreInformation]</a>

Chan, K., Simpson, P., Yong, A., Dunn, L., Chawantanpipat,C., Hsu, C., Yu, Y., Keech, A., Celermajer, D., Ng, M. (2014).The Relationship between Endothelial Progenitor CellPopulations and Epicardial and Microvascular CoronaryDisease-A Cellular, Angiographic and Physiologic Study. PloSOne, 9(4), 1-12. <ahref="http://dx.doi.org/10.1371/journal.pone.0093980">[MoreInformation]</a>

Ganigara, M., Tanous, D., Celermajer, D., Puranik, R. (2014).The role of cardiac MRI in the diagnosis and management ofsinus venosus atrial septal defect. Annals of PediatricCardiology, 7(2), 160-162. <ahref="http://dx.doi.org/10.4103/0974-2069.132509">[MoreInformation]</a>

Martinez, G., Ng, B., Wilson, M., Pasupati, S., Robinson, D.,Cartwright, B., Adams, M., Celermajer, D., Ng, M. (2014).Transcatheter Valve-in-Valve Replacement in ComplexCyanotic Congenital Heart Disease With a Single Ventricle.JACC: Cardiovascular Interventions, 7(10), e133-e133. <ahref="http://dx.doi.org/10.1016/j.jcin.2014.02.021">[MoreInformation]</a>

Iyengar, A., Winlaw, D., Galati, J., Celermajer, D., Wheaton,G., Gentles, T., Grigg, L., Weintraub, R., Bullock, A., Justo, R.,et al (2014). Trends in Fontan surgery and risk factors for earlyadverse outcomes after Fontan surgery: The Australia and NewZealand Fontan Registry experience. Journal of Thoracic andCardiovascular Surgery, 148(2), 566-575. <ahref="http://dx.doi.org/10.1016/j.jtcvs.2013.09.074">[MoreInformation]</a>

Woo, K., Kwok, T., Celermajer, D. (2014). Vegan Diet,Subnormal Vitamin B-12 Status and Cardiovascular Health.Nutrients, 6(8), 3259-3273. <ahref="http://dx.doi.org/10.3390/nu6083259">[MoreInformation]</a>

Skilton, M., Sullivan, T., Ayer, J., Garden, F., Harmer, J.,Leeder, S., Toelle, B., Webb, K., Marks, G., Celermajer, D.(2014). Weight gain in infancy is associated with carotid extra-medial thickness in later childhood. Atherosclerosis, 233(2),

370-374. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2014.01.020">[More Information]</a>

2013Lau, E., Morgan, P., Belousova, E., Toelle, B., Ayer, J.,Celermajer, D., Marks, G. (2013). Asymmetricdimethylarginine and asthma: results from the ChildhoodAsthma Prevention Study. European Respiratory Journal,41(5), 1234-1237. <ahref="http://dx.doi.org/10.1183/09031936.00162212">[MoreInformation]</a>

Low, A., Celermajer, D. (2013). Author reply. InternalMedicine Journal, 43(5), 609-609. <ahref="http://dx.doi.org/10.1111/imj.12113">[MoreInformation]</a>

O'Meagher, S., Choudhary, P., Duflou, J., Puranik, R.,Celermajer, D. (2013). Causes of death in tetralogy of Fallot inadults - An autopsy study. International Journal of Cardiology,168(2), 1547-1548. <ahref="http://dx.doi.org/10.1016/j.ijcard.2012.12.030">[MoreInformation]</a>

Marijon, E., Bougouin, W., Celermajer, D., Perier, M., Dumas,F., Benameur, N., Karam, N., Lamhaut, L., Tafflet, M.,Mustafic, H., et al (2013). Characteristics and outcomes ofsudden cardiac arrest during sports in women. Circulation.Arrhythmia and Electrophysiology, 6(6), 1185-1191. <ahref="http://dx.doi.org/10.1161/CIRCEP.113.000651">[MoreInformation]</a>

Levy, M., Bonnet, D., Mauge, L., Celermajer, D., Gaussem, P.,Smadja, D. (2013). Circulating endothelial cells in refractorypulmonary hypertension in children: markers of treatmentefficacy and clinical worsening. PloS One, 8(6), 1-10. <ahref="http://dx.doi.org/10.1371/journal.pone.0065114">[MoreInformation]</a>

Levy, M., Celermajer, D., Szezepanski, I., Boudjemline, Y.,Bonnet, D. (2013). Do tertiary paediatric hospitals deal with thesame spectrum of paediatric pulmonary hypertension as multicentre registries? European Respiratory Journal, 41(1),236-239. <ahref="http://dx.doi.org/10.1183/09031936.00114212">[MoreInformation]</a>

Simpson, P., Hoyos, C., Celermajer, D., Liu, P., Ng, M. (2013).Effects of continuous positive airway pressure on endothelialfunction and circulating progenitor cells in obstructive sleepapnoea: A randomised sham-controlled study. InternationalJournal of Cardiology, 168(3), 2042-2048. <ahref="http://dx.doi.org/10.1016/j.ijcard.2013.01.166">[MoreInformation]</a>

Kapellas, K., Do, L., Bartold, M., Skilton, M., Maple-Brown,L., O'Dea, K., Brown, A., Celermajer, D., Slade, G., Jamieson,L. (2013). Effects of full-mouth scaling on the periodontalhealth of Indigenous Australians: a randomized controlled trial.Journal of Clinical Periodontology, 40(11), 1016-1024. <ahref="http://dx.doi.org/10.1111/jcpe.12152">[MoreInformation]</a>

Beurtheret, S., Mordant, P., Paoletti, X., Marijon, E.,Celermajer, D., Leger, P., Pavie, A., Combes, A., Leprince, P.(2013). Emergency circulatory support in refractory cardiogenicshock patients in remote institutions: a pilot study (the cardiac-RESCUE program). European Heart Journal, 34(2), 112-120.<a href="http://dx.doi.org/10.1093/eurheartj/ehs081">[MoreInformation]</a>

Celermajer, D., Neal, B. (2013). Excessive Sodium Intake and

Cardiovascular Disease: A-Salting Our Vessels. Journal of theAmerican College of Cardiology, 61(3), 344-345. <ahref="http://dx.doi.org/10.1016/j.jacc.2012.08.998">[MoreInformation]</a>

Skilton, M., Mikkila, V., Wurtz, P., Ala-Korpela, M., Sim, K.,Soininen, P., Kangas, A., Viikari, J., Juonala, M., Laitinen, T.,Celermajer, D., et al (2013). Fetal growth, omega-3 (n-3) fattyacids, and progression of subclinical atherosclerosis: preventingfetal origins of disease? The Cardiovascular Risk in YoungFinns Study 1-3. American Journal of Clinical Nutrition, 97(1),58-65. <ahref="http://dx.doi.org/10.3945/ajcn.112.044198">[MoreInformation]</a>

Plichart, M., Thomas, F., Empana, J., Bean, K., Perier, M.,Celermajer, D., Hanona, O., Danchin, N., Pannier, B., Jouven,X. (2013). Gender-specific trends in heart rate in the generalpopulation from 1992-2007: a study of 226,288 French adults.European Journal of Preventive Cardiology, 20(1), 61-72. <ahref="http://dx.doi.org/10.1177/2047487311434231">[MoreInformation]</a>

Skilton, M., Raitakari, O., Celermajer, D. (2013). High Intakeof Dietary Long-Chain {omega}-3 Fatty Acids Is AssociatedWith Lower Blood Pressure in Children Born With Low BirthWeight: NHANES 2003-2008. Hypertension, 61(5), 972-976.<ahref="http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.01030">[More Information]</a>

Canniffe, C., Ou, P., Walsh, K., Bonnet, D., Celermajer, D.(2013). Hypertension after repair of aortic coarctation - Asystematic review. International Journal of Cardiology, 167(6),2456-2461. <ahref="http://dx.doi.org/10.1016/j.ijcard.2012.09.084">[MoreInformation]</a>

Hu, Y., Wei, A., Chook, P., Yin, Y., Cheng, W., Wu, M.,Celermajer, D., Woo, K. (2013). Impact of non-cardiovascularsurgery on reactive hyperaemia and arterial endothelialfunction. Clinical and Experimental Pharmacology andPhysiology, 40(7), 466-472. <ahref="http://dx.doi.org/10.1111/1440-1681.12111">[MoreInformation]</a>

Marijon, E., Bougouin, W., Perier, M., Celermajer, D., Jouven,X. (2013). Incidence of sports-related sudden death in Franceby specific sports and sex. JAMA, 310(6), 642-643. <ahref="http://dx.doi.org/10.1001/jama.2013.8711">[MoreInformation]</a>

Marijon, E., Bougouin, W., Celermajer, D., Perier, M.,Benameur, N., Lamhaut, L., Karam, N., Dumas, F., Tafflet, M.,Prugger, C., et al (2013). Major regional disparities in outcomesafter sudden cardiac arrest during sports. European HeartJournal, 34(47), 3632-3640. <ahref="http://dx.doi.org/10.1093/eurheartj/eht282">[MoreInformation]</a>

Ou, P., Khraiche, D., Celermajer, D., Agnoletti, G., Le QuanSang, K., Thalabard, J., Quintin, M., Raisky, O., Vouhe, P.,Sidi, D., et al (2013). Mechanisms of coronary complicationsafter the arterial switch for transposition of the great arteries.Journal of Thoracic and Cardiovascular Surgery, 145(5), 1263-1269. <ahref="http://dx.doi.org/10.1016/j.jtcvs.2012.06.009">[MoreInformation]</a>

Marijon, E., Tafflet, M., Antero-Jacquemin, J., El Helou, N.,Berthelot, G., Celermajer, D., Bougouin, W., Combes, N.,Hermine, O., Empana, J., et al (2013). Mortality of Frenchparticipants in the Tour de France (1947-2012). EuropeanHeart Journal, 34(40), 3145-3150. <ahref="http://dx.doi.org/10.1093/eurheartj/eht347">[More

Information]</a>

O'Meagher, S., Celermajer, D., Puranik, R. (2013). Preservedstroke volume late after tetralogy repair, despite severe rightventricular dilatation. Heart, 99(24), 1875-1876. <ahref="http://dx.doi.org/10.1136/heartjnl-2013-304620">[MoreInformation]</a>

Lau, E., Jaijee, S., Melehan, K., Wong, K., Yee, B., Grunstein,R., Celermajer, D. (2013). Prevalence of patent foramen ovaleand its impact on oxygen desaturation in obstructive sleepapnea. International Journal of Cardiology, 165(1), 35-40. <ahref="http://dx.doi.org/10.1016/j.ijcard.2011.07.050">[MoreInformation]</a>

Cordina, R., O'Meagher, S., Karmali, A., Rae, C., Liess, C.,Kemp, G., Puranik, R., Singh, N., Celermajer, D. (2013).Resistance training improves cardiac output, exercise capacityand tolerance to positive airway pressure in Fontan physiology.International Journal of Cardiology, 168(2), 780-788. <ahref="http://dx.doi.org/10.1016/j.ijcard.2012.10.012">[MoreInformation]</a>

Jaijee, S., O'Rourke, R., Puranik, R., Slaughter, R., Strugnal,W., Celermajer, D., Kermeen, F. (2013). Right to leftventricular volume ratio: A novel marker of disease severity inchronic thromboembolic pulmonary hypertension. IJC Heart &Vessels, 1, 17-21. <ahref="http://dx.doi.org/10.1016/j.ijchv.2013.10.001">[MoreInformation]</a>

Low, A., Fowler, D., Manghani, M., Young, I., Garsia, R.,Torzillo, P., Youssef, P., Celermajer, D. (2013). Screening andTreating Pulmonary Arterial Hypertension in a TertiaryHospital-based Multidisciplinary Clinic: The First 200 Patients.Internal Medicine Journal, 43(1), 32-37. <ahref="http://dx.doi.org/10.1111/j.1445-5994.2011.02624.x">[More Information]</a>

Cordina, R., O'Meagher, S., Gould, H., Rae, C., Kemp, G.,Pasco, J., Celermajer, D. (2013). Skeletal muscle abnormalitiesand exercise capacity in adults with a Fontan circulation. Heart,99(20), 1530-1534. <a href="http://dx.doi.org/10.1136/heartjnl-2013-304249">[More Information]</a>

Ladouceur, M., Kachenoura, N., Lefort, M., Redheuil, A.,Bonnet, D., Celermajer, D., Iserin, L., Mousseaux, E. (2013).Structure and function of the ascending aorta in palliatedtransposition of the great arteries. International Journal ofCardiology, 165(3), 458-462. <ahref="http://dx.doi.org/10.1016/j.ijcard.2011.08.847">[MoreInformation]</a>

Offen, S., Celermajer, D., Semsarian, C., Puranik, R. (2013).The role of diastolic filling in preserving left ventricular strokevolume - An MRI study. International Journal of Cardiology,168(2), 1596-1598. <ahref="http://dx.doi.org/10.1016/j.ijcard.2013.01.039">[MoreInformation]</a>

Schuuring, M., Bouma, B., Cordina, R., Gatzoulis, M., Budts,W., Mullen, M., Vis, J., Celermajer, D., Mulder, B. (2013).Treatment of segmental pulmonary artery hypertension in adultswith congenital heart disease. International Journal ofCardiology, 164(1), 106-110. <ahref="http://dx.doi.org/10.1016/j.ijcard.2011.06.084">[MoreInformation]</a>

Blyton, D., Skilton, M., Edwards, N., Hennessy, A., Celermajer,D., Sullivan, C. (2013). Treatment of sleep disordered breathingreverses low fetal activity levels in preeclampsia. Sleep, 36(1),15-21. <a href="http://dx.doi.org/10.5665/sleep.2292">[MoreInformation]</a>

Simonneau, G., Gatzoulis, M., Adatia, I., Celermajer, D.,Denton, C., Ghofrani, A., Angel Gomez Sanchez, M., Kumar,

R., Landzberg, M., Machado, R., et al (2013). Updated ClinicalClassification of Pulmonary Hypertension. Journal of theAmerican College of Cardiology, 62(25 Suppl D), D34-D41. <ahref="http://dx.doi.org/10.1016/j.jacc.2013.10.029">[MoreInformation]</a>

Skilton, M., Marks, G., Ayer, J., Garden, F., Garnett, S.,Harmer, J., Leeder, S., Toelle, B., Webb, K., Baur, L.,Celermajer, D. (2013). Weight gain in infancy and vascular riskfactors in later childhood. Pediatrics, 131(6), e1821-e1828. <ahref="http://dx.doi.org/10.1542/peds.2012-2789">[MoreInformation]</a>

2012Lau, E., Iyer, N., Ilsar, R., Bailey, B., Adams, M., Celermajer,D. (2012). Abnormal Pulmonary Artery Stiffness in PulmonaryArterial Hypertension: In Vivo Study with IntravascularUltrasound. PloS One, 7(3), 1-6. <ahref="http://dx.doi.org/10.1371/journal.pone.0033331">[MoreInformation]</a>

McGrath, K., Li, X., Gaus, K., Williams, P., Celermajer, D.,Handelsman, D., Heather, A. (2012). Androgens RapidlyActivate Nuclear Factor-Kappa B via Intracellular Ca2Signalling in Human Vascular Endothelial Cells. Journal ofSteroids & Hormonal Science, S2, 1-6. <ahref="http://dx.doi.org/10.4172/2157-7536.S2-005">[MoreInformation]</a>

Ting, R., Keech, A., Drury, P., Donoghoe, M., Hedley, J.,Jenkins, A., Davis, T., Lehto, S., Celermajer, D., Simes, R.,Rajamani, K., et al (2012). Benefits and Safety of Long-TermFenofibrate Therapy in People With Type 2 Diabetes and RenalImpairment - The FIELD Study. Diabetes Care, 35(2), 218-225. <a href="http://dx.doi.org/10.2337/dc11-1109">[MoreInformation]</a>

Celermajer, D., Chow, C., Marijon, E., Anstey, N., Woo, K.(2012). Cardiovascular Disease in the Developing World:Prevalences, Patterns, and the Potential of Early DiseaseDetection. Journal of the American College of Cardiology,60(14), 1207-1216. <ahref="http://dx.doi.org/10.1016/j.jacc.2012.03.074">[MoreInformation]</a>

Skilton, M., Sullivan, T., Ayer, J., Harmer, J., Toelle, B., Webb,K., Marks, G., Celermajer, D. (2012). Carotid extra-medialthickness in childhood: Early life effects on the arterialadventitia. Atherosclerosis, 222(2), 478-482. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2012.03.032">[More Information]</a>

Rose, M., Strange, G., King, I., Arnuop, S., Vidmar, S.,O'Donnell, C., Kermeen, F., Grigg, L., Weintraub, R.,Celermajer, D. (2012). Congenital heart disease-associatedpulmonary arterial hypertension: preliminary results from anovel registry. Internal Medicine Journal, 42(8), 874-879. <ahref="http://dx.doi.org/10.1111/j.1445-5994.2011.02708.x">[More Information]</a>

Dalton, B., McNeil, K., Keogh, A., Williams, T., Proudman, S.,Gabbay, E., Kotlyar, E., Weintraub, R., Kermeen, F.,Celermajer, D., et al (2012). Design and delivery of an e-learning curriculum for physicians involved in the managementof pulmonary hypertension. International Journal of ClinicalPractice, 66(11), 1117-1124. <ahref="http://dx.doi.org/10.1111/j.1742-1241.2012.02997.x">[More Information]</a>

O'Meagher, S., Munoz, P., Alison, J., Young, I., Tanous, D.,Celermajer, D., Puranik, R. (2012). Exercise capacity andstroke volume are preserved late after tetralogy repair, despitesevere right ventricular dilatation. Heart, 98(21), 1595-1599. <ahref="http://dx.doi.org/10.1136/heartjnl-2012-302147">[More

Information]</a>

Talib, J., Pattison, D., Harmer, J., Celermajer, D., Davies, M.(2012). High plasma thiocyanate levels modulate proteindamage induced by myeloperoxidase and perturb measurementof 3-chlorotyrosine. Free Radical Biology and Medicine, 53(1),20-29. <ahref="http://dx.doi.org/10.1016/j.freeradbiomed.2012.04.018">[More Information]</a>

Skilton, M., Ayer, J., Harmer, J., Webb, K., Leeder, S., Marks,G., Celermajer, D. (2012). Impaired Fetal Growth and ArterialWall Thickening: A Randomized Trial of Omega-3Supplementation. Pediatrics, 129(3), e698-e703. <ahref="http://dx.doi.org/10.1542/peds.2011-2472">[MoreInformation]</a>

Don, G., Joseph, F., Celermajer, D., Corte, T. (2012). Ironiccase of hepatic dysfunction following the global withdrawal ofsitaxentan. Internal Medicine Journal, 42(12), 1351-1354. <ahref="http://dx.doi.org/10.1111/imj.12007">[MoreInformation]</a>

Zahnd, G., Vray, D., Serusclat, A., Alibay, D., Bartold, M.,Brown, A., Durand, M., Jamieson, L., Kapellas, K., Maple-Brown, L., Celermajer, D., Skilton, M., et al (2012).Longitudinal displacement of the carotid wall andcardiovascular risk factors: associations with aging, adiposity,blood pressure and periodontal disease independent of cross-sectional distensibility and intima-media thickness. Ultrasoundin Medicine and Biology, 38(10), 1705-1715. <ahref="http://dx.doi.org/10.1016/j.ultrasmedbio.2012.05.004">[More Information]</a>

Morton, J., Zoungas, S., Li, Q., Patel, A., Chalmers, J.,Woodward, M., Celermajer, D., Beulens, J., Stolk, R., Glasziou,P., Ng, M. (2012). Low HDL Cholesterol and the Risk ofDiabetic Nephropathy and Retinopathy: Results of theADVANCE study. Diabetes Care, 35(11), 2201-2206. <ahref="http://dx.doi.org/10.2337/dc12-0306">[MoreInformation]</a>

Celermajer, D. (2012). Manipulating nature: Might there be acardiovascular price to pay for the miracle of assistedconception? Circulation, 125(15), 1832-1834. <ahref="http://dx.doi.org/10.1161/CIRCULATIONAHA.112.100479">[More Information]</a>

Thakkar, V., Stevens, W., Prior, D., Moore, O., Byron, J., Liew,D., Patterson, K., Hissaria, P., Roddy, J., Zochling, J.,Celermajer, D., Youssef, P., et al (2012). N-terminal pro-brainnatriuretic peptide in a novel screening algorithm for pulmonaryarterial hypertension in systemic sclerosis: a case-control study.Arthritis Research and Therapy, 14(3), 1-10. <ahref="http://dx.doi.org/10.1186/ar3876">[MoreInformation]</a>

Marshall, N., Ayer, J., Toelle, B., Phillips, C., Grunstein, R.,Celermajer, D., Marks, G. (2012). Parentally Reported SnoringIs Not Enough Information To Justify Treatment. Journal ofPaediatrics and Child Health, 48(1), 78-78. <ahref="http://dx.doi.org/10.1111/j.1440-1754.2011.02402.x">[More Information]</a>

Marijon, E., Mirabel, M., Celermajer, D., Jouven, X. (2012).Rheumatic heart disease. The Lancet, 379(9819), 953-964. <ahref="http://dx.doi.org/10.1016/S0140-6736(11)61171-9">[More Information]</a>

Mirabel, M., Celermajer, D., Ferreira, B., Tafflet, M., Perier,M., Karam, N., Mocumbi, A., Jani, D., Sidi, D., Jouven, X.,Marijon, E. (2012). Screening for rheumatic heart disease:evaluation of a simplified echocardiography-based approach.European journal of Echocardiography, 13(12), 1024-1029. <ahref="http://dx.doi.org/10.1093/ehjci/jes077">[More

Information]</a>

Golzan, S., Leaney, J., Cordina, R., Avolio, A., Celermajer, D.,Graham, S. (2012). Spontaneous retinal venous pulsatility inpatients with cyanotic congenital heart disease. Heart andVessels: an international journal, 27(6), 618-623. <ahref="http://dx.doi.org/10.1007/s00380-011-0201-x">[MoreInformation]</a>

Cordina, R., Celermajer, D., McGuire, M. (2012). Systemicvenous anatomy in congenital heart disease: implications forelectrophysiologic testing and catheter ablation. Journal ofInterventional Cardiac Electrophysiology, 33(2), 143-149. <ahref="http://dx.doi.org/10.1007/s10840-011-9624-7">[MoreInformation]</a>

Flammer, A., Anderson, T., Celermajer, D., Creager, M.,Deanfield, J., Ganz, P., Hamburg, N., Luscher, T., Shechter, M.,Taddei, S., et al (2012). The assessment of endothelial function:from research into clinical practice. Circulation, 126(6), 753-767. <ahref="http://dx.doi.org/10.1161/CIRCULATIONAHA.112.093245">[More Information]</a>

Rangan, A., Flood, V., Denyer, G., Ayer, J., Webb, K., Marks,G., Celermajer, D., Gill, T. (2012). The effect of dairyconsumption on blood pressure in mid-childhood: CAPS cohortstudy. European Journal of Clinical Nutrition, 66(6), 652-657.<a href="http://dx.doi.org/10.1038/ejcn.2011.218">[MoreInformation]</a>

Kwok, T., Chook, P., Qiao, M., Tam, L., Poon, Y., Ahuja, A.,Woo, J., Celermajer, D., Woo, K. (2012). Vitamin B-12supplementation improves arterial function in vegetarians withsubnormal vitamin B-12 status. Journal of Nutrition, Healthand Aging, 16(6), 569-573. <ahref="http://dx.doi.org/10.1007/s12603-012-0036-x">[MoreInformation]</a>

2011Levy, M., Celermajer, D., Bourges-Petit, E., Del Cerro, M.,Bajolle, F., Bonnet, D. (2011). Add-on therapy withsubcutaneous treprostinil for refractory pediatric pulmonaryhypertension. The Journal of Pediatrics, 158(4), 584-588. <ahref="http://dx.doi.org/10.1016/j.jpeds.2010.09.025">[MoreInformation]</a>

Davis, J., Darcy, C., Yeo, T., Jones, C., McNeil, Y., Stephens,D., Celermajer, D., Anstey, N. (2011). Asymmetricdimethylarginine, endothelial nitric oxide bioavailability andmortality in sepsis. PloS One, 6(2), e17260-1-e17260-6. <ahref="http://dx.doi.org/10.1371/journal.pone.0017260">[MoreInformation]</a>

Plichart, M., Celermajer, D., Zureik, M., Helmer, C., Jouven,X., Ritchie, K., Tzourio, C., Ducimetière, P., Empana, J.(2011). Carotid intima-media thickness in plaque-free site,carotid plaques and coronary heart disease risk prediction inolder adults. The Three-City Study. Atherosclerosis, 219(2),917-924. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2011.09.024">[More Information]</a>

Lau, E., Manes, A., Celermajer, D., Galie, N. (2011). Earlydetection of pulmonary vascular disease in pulmonary arterialhypertension: time to move forward. European Heart Journal,32(20), 2489-2498. <ahref="http://dx.doi.org/10.1093/eurheartj/ehr160">[MoreInformation]</a>

Skilton, M., Viikari, J., Juonala, M., Laitinen, T., Lehtimaki, T.,Taittonen, L., Kahonen, M., Celermajer, D., Raitakari, O.(2011). Fetal Growth and Preterm Birth InfluenceCardiovascular Risk Factors and Arterial Health in Young

Adults: The Cardiovascular Risk in Young Finns Study.Arteriosclerosis, Thrombosis, and Vascular Biology, 31(12),2975-2981. <ahref="http://dx.doi.org/10.1161/ATVBAHA.111.234757">[More Information]</a>

Jouven, X., Escolano, S., Celermajer, D., Empana, J., Bingham,A., Hermine, O., Desnos, M., Perier, M., Marijon, E.,Ducimetiere, P. (2011). Heart rate and risk of cancer death inhealthy men. PloS One, 6(8), e21310 - 1-e21310 - 7. <ahref="http://dx.doi.org/10.1371/journal.pone.0021310">[MoreInformation]</a>

Morgan, P., Pattison, D., Talib, J., Summers, F., Harmer, J.,Celermajer, D., Hawkins, C., Davies, M. (2011). High plasmathiocyanate levels in smokers are a key determinant of thioloxidation induced by myeloperoxidase. Free Radical Biologyand Medicine, 51(9), 1815-1822. <ahref="http://dx.doi.org/10.1016/j.freeradbiomed.2011.08.008">[More Information]</a>

Ng, A., Chung, T., Yong, A., Wong, H., Chow, V., Celermajer,D., Kritharides, L. (2011). Long-Term Cardiovascular andNoncardiovascular Mortality of 1023 Patients With Confirmed Acute Pulmonary Embolism. Circulation: CardiovascularQuality and Outcomes, 4(1), 122-128. <ahref="http://dx.doi.org/10.1161/CIRCOUTCOMES.110.958397">[More Information]</a>

Ayer, J., Belousova, E., Harmer, J., Toelle, B., Celermajer, D.,Marks, G. (2011). Lung Function Is Associated with ArterialStiffness in Children. PloS One, 6(10), e26303 - 1-e26303 - 4.<ahref="http://dx.doi.org/10.1371/journal.pone.0026303">[MoreInformation]</a>

Ayer, J., Belousova, E., Harmer, J., David, C., Marks, G.,Celermajer, D. (2011). Maternal cigarette smoking is associatedwith reduced high-density lipoprotein cholesterol in healthy 8-year-old children. European Heart Journal, 32(19), 2446-2453.<a href="http://dx.doi.org/10.1093/eurheartj/ehr174">[MoreInformation]</a>

Roberts, P., Boudjemline, Y., Cheatham, J., Eicken, A., Ewert,P., McElhinney, D., Hill, S., Berger, F., Khan, D., Schranz, D.,Celermajer, D., et al (2011). Percutaneous Tricuspid ValveReplacement in Congenital and Acquired Heart Disease.Journal of the American College of Cardiology, 58(2), 117-122.<a href="http://dx.doi.org/10.1016/j.jacc.2011.01.044">[MoreInformation]</a>

Ayer, J., Harmer, J., David, C., Steinbeck, K., Seale, J.,Celermajer, D. (2011). Severe obesity is associated withimpaired arterial smooth muscle function in young adults.Obesity, 19(1), 54-60. <ahref="http://dx.doi.org/10.1038/oby.2010.114">[MoreInformation]</a>

Marshall, N., Ayer, J., Toelle, B., Harmer, J., Phillips, C.,Grunstein, R., Celermajer, D., Marks, G. (2011). Snoring is notassociated with adverse effects on blood pressure, arterialstructure or function in 8-year-old children: The ChildhoodAsthma Prevention Study (CAPS). Journal of Paediatrics andChild Health, 47(8), 518-523. <ahref="http://dx.doi.org/10.1111/j.1440-1754.2011.02014.x">[More Information]</a>

Marijon, E., Tafflet, M., Celermajer, D., Dumas, F., Perier, M.,Mustafic, H., Toussaint, J., Desnos, M., Rieu, M., Benameur,N., et al (2011). Sports-related sudden death in the generalpopulation. Circulation, 124(6), 672-681. <ahref="http://dx.doi.org/10.1161/CIRCULATIONAHA.110.008979">[More Information]</a>

Skilton, M., Maple-Brown, L., Kapellas, K., Celermajer, D.,Bartold, P., Brown, A., O'Dea, K., Slade, G., Jamieson, L.(2011). The effect of a periodontal intervention oncardiovascular risk markers in Indigenous Australians withperiodontal disease: the PerioCardio study. BMC Public Health,11(1), 729-1-729-8. <a href="http://dx.doi.org/10.1186/1471-2458-11-729">[More Information]</a>

Iyer, N., Lau, E., Ilsar, R., Celermajer, D. (2011). Treatmentresponsiveness in pulmonary arterial hypertension-Preliminaryreport on serial intra-arterial Doppler flow velocity waveformmeasurements. International Journal of Cardiology, 153(2),219-221. <ahref="http://dx.doi.org/10.1016/j.ijcard.2011.09.061">[MoreInformation]</a>

Smadja, D., Mauge, L., Gaussem, P., d'Audigier, C., Israel-Biet, D., Celermajer, D., Bonnet, D., Levy, M. (2011).Treprostinil increases the number and angiogenic potential ofendothelial progenitor cells in children with pulmonaryhypertension. Angiogenesis, 14(1), 17-27. <ahref="http://dx.doi.org/10.1007/s10456-010-9192-y">[MoreInformation]</a>

Changsirivathanathamrong, D., Wang, Y., Rajbhandari, D.,Maghzal, G., Mak, W., Woolfe, C., Duflou, J., Gebski, V., DosRemedios, C., Celermajer, D., Stocker, R. (2011). Tryptophanmetabolism to kynurenine is a potential novel contributor tohypotension in human sepsis. Critical Care Medicine, 39(12),2678-2683. <ahref="http://dx.doi.org/10.1097/CCM.0b013e31822827f2">[More Information]</a>

2010Sieveking, D., Lim, P., Chow, R., Dunn, L., Bao, B., McGrath,K., Heather, A., Handelsman, D., Celermajer, D., Ng, M.(2010). A sex-specific role for androgens in angiogenesis. TheJournal of Experimental Medicine, 207(2), 345-352. <ahref="http://dx.doi.org/10.1084/jem.20091924">[MoreInformation]</a>

Davis, J., Yeo, T., Piera, K., Woodberry, T., Celermajer, D.,Stephens, D., Anstey, N. (2010). Angiopoietin-2 is increased insepsis and inversely associated with nitric oxide-dependentmicrovascular reactivity. Critical Care, 14: R89(3), 1-8. <ahref="http://dx.doi.org/10.1186/cc9020">[MoreInformation]</a>

Patel, S., Di Bartolo, B., Nakhla, S., Heather, A., Mitchell, T.,Jessup, W., Celermajer, D., Barter, P., Rye, K. (2010). Anti-inflammatory effects of apolipoprotein A-I in the rabbit.Atherosclerosis, 212(2), 392-397. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2010.05.035">[More Information]</a>

Ilsar, R., Levitt, J., Ng, M., Kritharides, L., Celermajer, D.(2010). Bosentan and improved pulmonary endothelial functionin pulmonary arterial hypertension. European RespiratoryJournal, 36(6), 1483-1485. <ahref="http://dx.doi.org/10.1183/09031936.00083910">[MoreInformation]</a>

Ayer, J., Harmer, J., Marks, G., Avolio, A., Celermajer, D.(2010). Central arterial pulse wave augmentation is greater ingirls than boys, independent of height. Journal of Hypertension,28(2), 306-313. <ahref="http://dx.doi.org/10.1097/HJH.0b013e3283332286">[More Information]</a>

Cordina, R., Celermajer, D. (2010). Chronic cyanosis andvascular function: implications for patients with cyanoticcongenital heart disease. Cardiology in the Young, 20(3), 242-53. <ahref="http://dx.doi.org/10.1017/S1047951110000466">[More

Information]</a>

Puranik, R., Celermajer, D., Muthurangu, V., Taylor, A.,Puranik, R. (2010). Congenital heart disease and multi-modalityimaging. Heart, Lung, and Circulation, 19(3), 133-144. <ahref="http://dx.doi.org/10.1016/j.hlc.2010.01.001">[MoreInformation]</a>

Ilsar, R., Chawantanpipat, C., Chan, K., Dobbins, T., Waugh,R., Hennessy, A., Celermajer, D., Ng, M. (2010). Doppler-derived Pulmonary Flow Reserve Detects PulmonaryMicrovascular Obstruction in High Primates. Heart, Lung, andCirculation, 19(10), 592-594. <ahref="http://dx.doi.org/10.1016/j.hlc.2010.06.1057">[MoreInformation]</a>

Mackie, F., Rosenberg, A., Harmer, J., Kainer, G., Celermajer,D. (2010). HMG CoA reductase inhibition and endothelialfunction in children with chronic kidney disease (CKD) - a pilotstudy. Acta Paediatrica: Nurturing the Child, 99(3), 457-459.<a href="http://dx.doi.org/10.1111/j.1651-2227.2009.01643.x">[More Information]</a>

Yeo, T., Lampah, D., Tjitra, E., Gitawati, R., Darcy, C., Jones,C., Kenangalem, E., McNeil, Y., Granger, D., Lopansri, B.,Celermajer, D., et al (2010). Increased AsymmetricDimethylarginine in Severe Falciparum Malaria: Associationwith Impaired Nitric Oxide Bioavailability and Fatal Outcome.PLoS Pathogens, 6(4), e1000868-1-e1000868-8. <ahref="http://dx.doi.org/10.1371/journal.ppat.1000868">[MoreInformation]</a>

Ayer, J., Song, C., Steinbeck, K., Celermajer, D., Freedman, B.(2010). Increased Tissue Factor Activity in Monocytes fromObese Young Adults. Clinical and Experimental Pharmacologyand Physiology, 37(11), 1049-1054. <ahref="http://dx.doi.org/10.1111/j.1440-1681.2010.05430.x">[More Information]</a>

Wang, Y., Liu, H., McKenzie, G., Witting, P., Stasch, J., Hahn,M., Changsirivathanathamrong, D., Wu, B., Ball, H., Thomas,S., Celermajer, D., Hunt, N., Stocker, R., et al (2010).Kynurenine is an endothelium-derived relaxing factor producedduring inflammation. Nature Medicine, 16(3), 279-285. <ahref="http://dx.doi.org/10.1038/nm.2092">[MoreInformation]</a>

Cordina, R., Celermajer, D. (2010). Late-Onset PulmonaryArterial Hypertension After a Successful Atrial or ArterialSwitch Procedure for Transposition of the Great Arteries.Pediatric Cardiology, 31(2), 238-241. <ahref="http://dx.doi.org/10.1007/s00246-009-9597-9">[MoreInformation]</a>

Ayer, J., Sholler, G., Celermajer, D. (2010). Left atrial sizeincreases with body mass index in children. InternationalJournal of Cardiology, 141(1), 61-67. <ahref="http://dx.doi.org/10.1016/j.ijcard.2008.11.157">[MoreInformation]</a>

Ilsar, R., Chawantanpipat, C., Chan, K., Dobbins, T., Waugh,R., Hennessy, A., Celermajer, D., Ng, M. (2010). Measurementof pulmonary flow reserve and pulmonary index ofmicrocirculatory resistance for detection of pulmonarymicrovascular obstruction. PloS One, 5(3), e9601 - 1-e9601 - 9.<ahref="http://dx.doi.org/10.1371/journal.pone.0009601">[MoreInformation]</a>

Lau, E., Yee, B., Grunstein, R., Celermajer, D. (2010). Patentforamen ovale and obstructive sleep apnea: A new association?Sleep Medicine Reviews, 14(6), 391-395. <ahref="http://dx.doi.org/10.1016/j.smrv.2010.02.002">[MoreInformation]</a>

Roberts, P., Spina, R., Vallely, M., Wilson, M., Bailey, B.,

Celermajer, D. (2010). Percutaneous tricuspid valvereplacement for a stenosed bioprosthesis. Circulation:Cardiovascular Interventions, 3(4), e14-e15. <ahref="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20716752">[MoreInformation]</a>

Ban, C., Twigg, S., Franjic, B., Brooks, B., Celermajer, D.,Yue, D., McLennan, S. (2010). Serum MMP-7 is increased indiabetic renal disease and diabetic diastolic dysfunction.Diabetes Research and Clinical Practice, 87(3), 335-341. <ahref="http://dx.doi.org/10.1016/j.diabres.2010.01.004">[MoreInformation]</a>

Ayer, J., Harmer, J., David, C., Steinbeck, K., Seale, J.,Celermajer, D. (2010). Severe Obesity Is Associated WithImpaired Arterial Smooth Muscle Function in Young Adults.Obesity, 19(1), 54-60. <ahref="http://dx.doi.org/10.1038/oby.2010.114">[MoreInformation]</a>

Patel, S., Chung, S., White, G., Bao, B., Celermajer, D. (2010).The "atheroprotective" mediators apolipoproteinA-I and Foxp3are over-abundant in unstable carotid plaques. InternationalJournal of Cardiology, 145(2), 183-187. <ahref="http://dx.doi.org/10.1016/j.ijcard.2009.05.024">[MoreInformation]</a>

Ilsar, R., Bailey, B., Dobbins, T., Celermajer, D. (2010). TheRelationship Between Pulmonary Artery and PulmonaryCapillary Wedge Pressure for the Diagnosis of PulmonaryVascular Disease. Heart, Lung, and Circulation, 19(1), 38-42.<a href="http://dx.doi.org/10.1016/j.hlc.2009.08.001">[MoreInformation]</a>

Cordina, R., Celermajer, D. (2010). Therapeutic approaches inadults with congenital heart disease-associated pulmonaryarterial hypertension. European Respiratory Review, 19(118),300-307. <ahref="http://dx.doi.org/10.1183/09059180.00004510">[MoreInformation]</a>

2009Patel, S., Puranik, R., Nakhla, S., Lundmand, P., Stocker, R.,Wang, X., Lambert, G., Rye, K., Barter, P., Nicholls, S.,Celermajer, D. (2009). Acute hypertriglyceridaemia in humansincreases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins.Atherosclerosis, 204(2), 424-428. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2008.07.047">[More Information]</a>

Ayer, J., Harmer, J., Xuan, W., Toelle, B., Webb, K., Almqvist,C., Marks, G., Celermajer, D. (2009). Dietary supplementationwith n-3 polyunsaturated fatty acids in early childhood: Effectson blood pressure and arterial structure and function at age 8 y1-3. American Journal of Clinical Nutrition, 90, 438-446. <ahref="http://dx.doi.org/10.3945/ajcn.2009.27811">[MoreInformation]</a>

Ayer, J., Harmer, J., Nakhla, S., Xuan, W., Ng, M., Raitakari,O., Marks, G., Celermajer, D. (2009). HDL-cholesterol, bloodpressure, and asymmetric dimethylarginine are significantlyassociated with arterial wall thickness in children.Arteriosclerosis, Thrombosis, and Vascular Biology, 29(6), 943-949. <ahref="http://dx.doi.org/10.1161/ATVBAHA.109.184184">[More Information]</a>

Ilsar, R., Chawantanpipat, C., Chan, K., Waugh, R., Hennessy,A., Celermajer, D., Ng, M. (2009). Measurement of pulmonaryflow reserve in higher primates. Clinical and ExperimentalPharmacology and Physiology, 36(8), 797-802. <ahref="http://dx.doi.org/10.1111/j.1440-

1681.2009.05160.x">[More Information]</a>

Ayer, J., Harmer, J., Steinbeck, K., Celermajer, D. (2009).Postprandial Vascular Reactivity in Obese and Normal WeightYoung Adults. Obesity, 18(5), 945-951. <ahref="http://dx.doi.org/10.1038/oby.2009.331">[MoreInformation]</a>

Chow, C., Joshi, R., Celermajer, D., Patel, A., Neal, B. (2009).Recalibration of a Framingham risk equation for a ruralpopulation in India. Journal of Epidemiology and CommunityHealth, 63(5), 379-385. <ahref="http://dx.doi.org/10.1136/jech.2008.077057">[MoreInformation]</a>

Patel, S., Drew, B., Nakhla, S., Duffy, S., Murphy, A., Barter,P., Rye, K., Chin-Dusting, J., Hoang, A., Sviridov, D.,Celermajer, D., et al (2009). Reconstituted high-densitylipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity inpatients with type 2 diabetes. Journal of the American Collegeof Cardiology, 53(11), 962-971. <ahref="http://dx.doi.org/10.1016/j.jacc.2008.12.008">[MoreInformation]</a>

Celermajer, D. (2009). Wait for weight or waste" the waist thebenefits of early intervention in childhood obesity.". Journal ofthe American College of Cardiology, 54(25), 2407-2408. <ahref="http://dx.doi.org/10.1016/j.jacc.2009.07.053">[MoreInformation]</a>

2008Agnoletti, G., Ou, P., Celermajer, D., Boudjemline, Y., Marini,D., Bonnet, D., Aggoun, Y. (2008). Acute angulation of theaortic arch predisposes a patient to ascending aortic dilatationand aortic regurgitation late after the arterial switch operationfor transposition of the great arteries. Journal of Thoracic andCardiovascular Surgery, 135(3), 568-572. <ahref="http://dx.doi.org/10.1016/j.jtcvs.2007.10.020">[MoreInformation]</a>

Yeo, T., Lampahc, D., Gitawatie, R., Tjitra, E., Kenangalem,E., Piera, K., Price, R., Duffull, S., Celermajer, D., Anstey, N.(2008). Angiopoietin-2 is associated with decreased endothelialnitric oxide and poor clinical outcome in severe falciparummalaria. Proceedings of the National Academy of Sciences ofthe United States of America, 105(44), 17097-17102. <ahref="http://dx.doi.org/10.1073/pnas.0805782105">[MoreInformation]</a>

Ou, P., Celermajer, D., Raisky, O., Jolivet, O., Buyens, F.,Herment, A., Sidi, D., Bonnet, D., Mousseaux, E. (2008).Angular (Gothic) aortic arch leads to enhanced systolic wavereflection, central aortic stiffness, and increased left ventricularmass late after aortic coarctation repair: evaluation withmagnetic resonance flow mapping. Journal of Thoracic andCardiovascular Surgery, 135(1), 62-68. <ahref="http://dx.doi.org/10.1016/j.jtcvs.2007.03.059">[MoreInformation]</a>

Patel, S., Celermajer, D., Bao, B. (2008). Atherosclerosis -Underlying inflammatory mechanisms and clinicalimplications. International Journal of Biochemistry and CellBiology, 40(4), 576-580. <ahref="http://dx.doi.org/10.1016/j.biocel.2007.11.017">[MoreInformation]</a>

Ayer, J., Almafragy, H., Patel, A., Hellyer, R., Celermajer, D.(2008). Body mass index is an independent determinant of leftatrial size. Heart, Lung, and Circulation, 17(1), 19-24. <ahref="http://dx.doi.org/10.1016/j.hlc.2007.04.006">[MoreInformation]</a>

McGrady, M., Thanyasiri, P., Bailey, B., Celermajer, D.,

Adams, M. (2008). Determinants of coronary arterial flow-mediated dilatation following percutaneous coronaryintervention. Catheterization and Cardiovascular Interventions,71(3), 327-332. <ahref="http://dx.doi.org/10.1002/ccd.21375">[MoreInformation]</a>

Chow, C., McQuillan, B., Raju, P., Iyengar, S., Raju, R.,Harmer, J., Neal, B., Celermajer, D. (2008). Greater adverseeffects of cholesterol and diabetes on carotid intima-mediathickness in South Asian Indians: Comparison of risk factor-IMT associations in two population-based surveys.Atherosclerosis, 199(1), 116-122. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2007.10.008">[More Information]</a>

Ou, P., Celermajer, D., Jolivet, O., Buyens, F., Herment, A.,Sidi, D., Bonnet, D., Mousseaux, E. (2008). Increased centralaortic stiffness and left ventricular mass in normotensive youngsubjects after successful coarctation repair. American HeartJournal, 155(1), 187-193. <ahref="http://dx.doi.org/10.1016/j.ahj.2007.09.008">[MoreInformation]</a>

Puranik, R., Bao, B., Nobecourt, E., Nicholls, S., Dusting, G.,Barter, P., Celermajer, D., Rye, K. (2008). Low doseapolipoprotein A-I rescues carotid arteries from inflammation invivo. Atherosclerosis, 196(1), 240-247. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2007.05.008">[More Information]</a>

Yeo, T., Lampah, D., Gitawati, R., Tjitra, E., Kenangalem, E.,McNeil, Y., Darcy, C., Granger, D., Weinberg, J., et al,Celermajer, D. (2008). Recovery of Endothelial Function inSevere Falciparum Malaria: Relationship with Improvement inPlasma l-Arginine and Blood Lactate Concentrations. TheJournal of Infectious Diseases, 198(4), 602-608. <ahref="http://dx.doi.org/10.1086/590209">[MoreInformation]</a>

Kilian, J., Thanyasiri, P., Celermajer, D., Adams, M. (2008).Saphenous Vein Grafts Display Poor Endothelium-Dependentand Endothelium-Independent Dilation - Implications for thePathogenesis of Vein Graft Atherosclerosis. Heart, Lung, andCirculation, 17(2), 96-99. <ahref="http://dx.doi.org/10.1016/j.hlc.2007.07.001">[MoreInformation]</a>

Chow, C., Naidu, S., Raju, P., Raju, R., Joshi, R., Sullivan, D.,Celermajer, D., Neal, B. (2008). Significant lipid, adiposity andmetabolic abnormalities amongst 4535 Indians from adeveloping region of rural Andhra Pradesh. Atherosclerosis,196, 943-952. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2007.02.027">[More Information]</a>

Thomas, G., Chook, P., Yip, T., Kwong, S., Chan, T., Qiao, M.,Huang, X., Guo, D., Feng, J., Chan, S., Celermajer, D., et al(2008). Smoking without exception adversely affects vascularstructure and function in apparently healthy Chinese:implications in global atherosclerosis prevention. InternationalJournal of Cardiology, 128(2), 172-177. <ahref="http://dx.doi.org/10.1016/j.ijcard.2007.11.065">[MoreInformation]</a>

Sieveking, D., Buckle, A., Celermajer, D., Ng, M. (2008).Strikingly different angiogenic properties of endothelialprogenitor cell subpopulations: insights from a novel humanangiogenesis assay. Journal of the American College ofCardiology, 51(6), 660-668. <ahref="http://dx.doi.org/10.1016/j.jacc.2007.09.059">[MoreInformation]</a>

Lattimore, J., Wilcox, I., Adams, M., Kilian, J., Celermajer, D.(2008). Treatment of obstructive sleep apnoea leads to

enhanced pulmonary vascular nitric oxide release. InternationalJournal of Cardiology, 126, 229-233. <ahref="http://dx.doi.org/10.1016/j.ijcard.2007.04.001">[MoreInformation]</a>

Celermajer, D., Ng, M. (2008). Where there's smoke.. Journalof the American College of Cardiology, 51(18), 1772-4. <ahref="http://dx.doi.org/10.1016/j.jacc.2008.02.031">[MoreInformation]</a>

2007Puranik, R., Greaves, K., Hawker, R., Pressley, L., Robinson,P., Celermajer, D. (2007). Abnormal Right Ventricular TissueVelocities After Repair of Congenital Heart Disease-Implications for Late Outcomes. Heart, Lung, and Circulation, 16(4), 295-299. <ahref="http://dx.doi.org/10.1016/j.hlc.2007.02.084">[MoreInformation]</a>

Patel, S., Drew, B., Duffy, S., Nahkla, S., Rye, K., Barter, P.,Celermajer, D., Kingwell, B. (2007). Abstract 1047: Infusion ofReconstituted High Density Lipoproteins Into HumansEnhances the In Vitro Anti-Inflammatory Capacity of the HighDensity Lipoprotein Fraction. Circulation, 116, II_209.

Chandrasegaram, M., Celermajer, D., Wilson, M. (2007).Apical ballooning syndrome complicated by acute severe mitralregurgitation with left ventricular outflow obstruction – Casereport. Journal of Cardiothoracic Surgery, 2(14), 1-14. <ahref="http://dx.doi.org/10.1186/1749-8090-2-14">[MoreInformation]</a>

Chow, C., Cardona-Morrell, M., Raju, P., Iyengar, S., Sukumar,A., Raju, C., Colman, S., Madhav, P., Raju, R., Reddy, K.,Celermajer, D., Neal, B. (2007). Cardiovascular disease andrisk factors among 345 adults in rural India-the Andhra PradeshRural Health Initiative. International Journal of Cardiology,116(2), 180-185. <ahref="http://dx.doi.org/10.1016/j.ijcard.2006.03.043">[MoreInformation]</a>

Patel, S., Harmer, J., Loughnan, G., Skilton, M., Steinbeck, K.,Celermajer, D. (2007). Characteristics of cardiac and vascularstructure and function in Prader-Willi syndrome. ClinicalEndocrinology, 66(6), 771-777. <ahref="http://dx.doi.org/10.1111/j.1365-2265.2007.02808.x">[More Information]</a>

Marijon, E., Trinquart, L., Jani, D., Jourdier, H., Garbarz, E.,Mocumbi, A., Celermajer, D., Ferreira, B. (2007). Coronaryheart disease and associated risk factors in sub-SaharanAfricans. Journal of Human Hypertension, 21(5), 411-414. <ahref="http://dx.doi.org/10.1038/sj.jhh.1002146">[MoreInformation]</a>

Ou, P., Celermajer, D., Agnoletti, G., Brunelle, F., Vouhe, P.,Sidi, D., Bonnet, D. (2007). Definitive diagnosis of pulmonaryartery sling in a critically ill infant with high resolutioncomputed tomography. Circulation, 115, e398-e399. <ahref="http://dx.doi.org/10.1161/CIRCULATIONAHA.106.668350">[More Information]</a>

Brooks, B., Franjic, B., Ban, C., Swaraj, K., Yue, D.,Celermajer, D., Twigg, S. (2007). Diastolic dysfunction andabnormalities of the microcirculation in type 2 diabetes.Diabetes, Obesity and Metabolism, online publication(doi:10.1111/j.1463-1326.2007.00803.x), 1-8. <ahref="http://dx.doi.org/10.1111/j.1463-1326.2007.00803.x">[More Information]</a>

Celermajer, D., Marwick, T. (2007). Echocardiographic andright heart catheterization techniques in patients withpulmonary arterial hypertension. International Journal of

Cardiology, 125, 294-303. <ahref="http://dx.doi.org/10.1016/j.ijcard.2007.04.184">[MoreInformation]</a>

Levy, M., Maurey, C., Celermajer, D., Vouhe, P., Danel, C.,Bonnet, D., Israel-Biet, D. (2007). Impaired apoptosis ofpulmonary endothelial cells is associated with intimalproliferation and irreversibility of pulmonary hypertension incongenital heart disease. Journal of the American College ofCardiology, 49(7), 803-810. <ahref="http://dx.doi.org/10.1016/j.jacc.2006.09.049">[MoreInformation]</a>

Yeo, T., Lampah, D., Gitawati, R., Tjitra, E., Kenangalem, E.,McNeil, Y., Darcy, C., Granger, D., Weinberg, J., Lopansri, B.,Celermajer, D., et al (2007). Impaired nitric oxidebioavailability and L-arginine-reversible endothelialdysfunction in adults with falciparum malaria. The Journal ofExperimental Medicine, 204(11), 2693-2704. <ahref="http://dx.doi.org/10.1084/jem.20070819">[MoreInformation]</a>

Maple-Brown, L., Piers, L., O'Rourke, M., Celermajer, D.,O'Dea, K. (2007). Increased arterial stiffness in remoteIndigenous Australians with high risk of cardiovascular disease.Journal of Hypertension, 25(3), 585-591. <ahref="http://dx.doi.org/10.1097/HJH.0b013e328011f766">[More Information]</a>

Maple-Brown, L., Cunningham, J., Celermajer, D., O'Dea, K.(2007). Increased carotid intima-media thickness in remote andurban Indigenous Australians: impact of diabetes andcomponents of the metabolic syndrome. ClinicalEndocrinology, 66(3), 419-425. <ahref="http://dx.doi.org/10.1111/j.1365-2265.2007.02749.x">[More Information]</a>

Marijon, E., Ou, P., Celermajer, D., Ferreira, B., Mocumbi, A.,Jani, D., Paquet, C., Jacob, S., Sidi, D., Jouven, X. (2007).Prevalence of Rheumatic Heart Disease Detected byEchocardiographic Screening. New England Journal ofMedicine, 357(5), 470-476. <ahref="http://dx.doi.org/10.1056/NEJMoa065085">[MoreInformation]</a>

Celermajer, D. (2007). Protecting children from passivesmoking. Circulation, 115, 3143-3144. <ahref="http://dx.doi.org/10.1161/CIRCULATIONAHA.107.709998">[More Information]</a>

Proudman, S., Stevens, W., Sahhar, J., Celermajer, D. (2007).Pulmonary arterial hypertension in systemic sclerosis: the needfor early detection and treatment. Internal Medicine Journal,37(7), 485-494. <a href="http://dx.doi.org/10.1111/j.1445-5994.2007.01370.x">[More Information]</a>

Webb, R., Wilson, N., Lennon, D., Marijon, E., Celermajer, D.,Jouven, X. (2007). Rheumatic Heart Disease Detected byEchocardiographic Screening. New England Journal ofMedicine, 357(20), 2088-2089. <ahref="http://dx.doi.org/10.1056/NEJMc072555">[MoreInformation]</a>

Skilton, M., Sieveking, D., Harmer, J., Franklin, J., Loughnan,G., Nakhla, S., Sullivan, D., Caterson, I., Celermajer, D. (2007).The effects of obesity and non-pharmacological weight loss onvascular and ventricular function and structure. Diabetes,Obesity and Metabolism, 10(10), 874-884. <ahref="http://dx.doi.org/10.1111/j.1463-1326.2007.00817.x">[More Information]</a>

Brand-Miller, J., Dickinson, S., Barclay, A., Celermajer, D.(2007). The glycemic index and cardiovascular disease risk.Current Atherosclerosis Reports, 9(6), 479-85. <ahref="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retri

eve&db=pubmed&dopt=Abstract&list_uids=18377788">[MoreInformation]</a>

Ou, P., Celermajer, D., Mousseux, E., Giron, A., Aggoun, Y.,Szezepanski, I., Sidi, D., Bonnet, D. (2007). Vascularremodelling after "successful" repair of coarctation: impact ofaortic arch geometry. Journal of the American College ofCardiology, 49(8), 883-890. <ahref="http://dx.doi.org/10.1016/j.jacc.2006.10.057">[MoreInformation]</a>

2006Celermajer, D. (2006). A new era of management in pulmonaryhypertension. World Congress of Cardiology.

Puranik, R., Bao, B., Celermajer, D., Rye, K., Barter, P.,Nicholls, S., Nobecourt, E. (2006). A single infusion of lipidfree apo A1 can rescue vascular inflammation. AtherosclerosisSupplements, 7, 153.

Puranik, R., Nobecourt, E., Bao, B., Davies, M., Barter, P.,Celermajer, D., Rye, K. (2006). Abstract 1355: The Impact ofGlycation on the Anti-inflammatory Properties of High DensityLipoproteins in vivo. Circulation, 114, II-257-II-258.

Ou, P., Mousseaux, E., Celermajer, D., Pedroni, E., Vouhe, P.,Sidi, D., Bonnet, D. (2006). Aortic arch shape deformation aftercoarctation surgery: effect on blood pressure response. Journalof Thoracic and Cardiovascular Surgery, 132(5), 1105-1111.<a href="http://dx.doi.org/10.1016/j.jtcvs.2006.05.061">[MoreInformation]</a>

Patel, S., Celermajer, D. (2006). Assessment of vascular diseaseusing arterial flow mediated dilatation. PharmacologicalReports, 58, 3-7. <ahref="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17332665">[MoreInformation]</a>

Kotlyar, E., Sy, R., Keogh, A., Kermeen, F., Macdonald, P.,Hayward, C., McNeil, K., Celermajer, D. (2006). Bosentan forthe treatment of pulmonary arterial hypertension associatedwith congenital cardiac disease. Cardiology in the Young, 16(3),268-274. <ahref="http://dx.doi.org/10.1017/S1047951106000114">[MoreInformation]</a>

Celermajer, D., Ayer, J. (2006). Childhood risk factors for adultcardiovascular disease and primary prevention in childhood.Heart, 92(11), 1701-1706. <ahref="http://dx.doi.org/10.1136/hrt.2005.081760">[MoreInformation]</a>

Nicholls, S., Lundman, P., Harmer, J., Cutri, B., Griffiths, K.,Rye, K., Barter, P., Celermajer, D. (2006). Consumption ofsaturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. Journal of theAmerican College of Cardiology, 48(4), 715-720. <ahref="http://dx.doi.org/10.1016/j.jacc.2006.04.080">[MoreInformation]</a>

Skilton, M., Celermajer, D. (2006). Endothelial dysfunction andarterial abnormalities in childhood obesity. InternationalJournal of Obesity, 30(7), 1041-1049. <ahref="http://dx.doi.org/10.1038/sj.ijo.0803397">[MoreInformation]</a>

Thanyasiri, P., Kathir, K., Celermajer, D., Adams, M. (2006).Endothelial dysfunction and restenosis following percutaneouscoronary intervention. International Journal of Cardiology,119(3), 362-367. <ahref="http://dx.doi.org/10.1016/j.ijcard.2006.08.015">[MoreInformation]</a>

Celermajer, D. (2006). Endothelial function in humans.

Jagellonian Medical Research Foundation.

Chow, C., McQuillan, B., Raju, K., Raju, R., Celermajer, D.(2006). High levels of subclinical atherosclerosis in rural southAsian Indians could be explained by impaired protection byHDL. Annual Scientific Session of the American College ofCardiology (2006), United States: Elsevier Inc.

Celermajer, D. (2006). How early should we measureendothelial dysfunction? World Congress of Cardiology.

Lau, A., Chaufour, X., McLachlan, C., Leichtweis, S.,Celermajer, D., Sullivan, C., Stocker, R. (2006). Intimalthickening after arterial balloon injury is increased byintermittent repetitive hypoxia, but intermittent repetitivehyperoxia is not protective. Atherosclerosis, 185(2), 254-263.<ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2005.06.040">[More Information]</a>

Skilton, M., Gosby, A., Wu, B., Ho, L., Stocker, R., Caterson,I., Celermajer, D. (2006). Maternal undernutrition reducesaortic wall thickness and elastin content in offspring rats without altering endothelial function. Clinical Science, 111(4),281-287. <ahref="http://dx.doi.org/10.1042/CS20060036">[MoreInformation]</a>

Celermajer, D. (2006). Physiology of the post-coarctation aorta.Image et Function Seminar.

Thanyasiri, P., Celermajer, D., Adams, M. (2006). Predictors oflong-term outcome following percutaneous coronaryintervention in patients with type 2 diabetes mellitus. CoronaryArtery Disease, 17(2), 131-138. <ahref="http://dx.doi.org/10.1097/00019501-200603000-00006">[More Information]</a>

Tanous, D., Brasen, J., Choy, K., Wu, B., Kathir, K., Lau, A.,Celermajer, D., Stocker, R. (2006). Probucol inhibits in-stentthrombosis and neointimal hyperplasia by promoting re-endothelialization. Atherosclerosis, 189(2), 342-349. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2006.01.025">[More Information]</a>

Skilton, M., Celermajer, D. (2006). The effects of obesity-related peptides on the vasculature. Current VascularPharmacology, 4(1), 79-85. <ahref="http://dx.doi.org/10.2174/157016106775203135">[MoreInformation]</a>

Woo, K., Yip, T., Kwong, S., Chook, P., Hu, Y., HUang, X.,Woo, L., Celermajer, D. (2006). The impact of vitamin B12 andfolic acid supplementation on atherosclerosis in rural Chinese:A novel strategy for atherosclerosis prevention in China. WorldCongress of Cardiology 2006, United Kingdom: OxfordUniversity Press.

Chow, C., Raju, P., Raju, K., Reddy, K., Cardona-Morrell, M.,Celermajer, D., Neal, B. (2006). The prevalence andmanagement of diabetes in rural Indian Adults. (Letter).Diabetes Care, 29(7), 1717-1718. <ahref="http://dx.doi.org/10.2337/dc06-0621">[MoreInformation]</a>

Ou, P., Celermajer, D., Calcagni, G., Brunelle, F., Bonnet, D.,Sidi, D. (2006). Three-Dimensional CT Scanning: A NovelDiagnostic Modality in Congenital Heart Disease. Heart, 93(8),908-913. <ahref="http://dx.doi.org/10.1136/hrt.2006.101352">[MoreInformation]</a>

Lattimore, J., Wilcox, I., Skilton, M., Langenfeld, M.,Celermajer, D. (2006). Treatment of obstructive sleep apnoealeads to improved microvascular endothelial function in the

systemic circulation. Thorax, 61(6), 491-495. <ahref="http://dx.doi.org/10.1136/thx.2004.039164">[MoreInformation]</a>

2005Kilian, J., Nakhla, S., Sieveking, D., Celermajer, D. (2005).Adenosine prevents neutrophil adhesion to human endothelialcells after hypoxia/reoxygenation. International Journal ofCardiology, 105(3), 322-326. <ahref="http://dx.doi.org/10.1016/j.ijcard.2005.03.010">[MoreInformation]</a>

Celermajer, D. (2005). Adult congenital heart disease. EchoAustralia Meeting.

Sader, M., McGrath, K., Hill, M., Bradstock, K., Jimenez, M.,Handelsman, D., Celermajer, D., Heather, A. (2005). Androgenreceptor gene expression in leucocytes is hormonally regulated: implications for gender differences indisease pathogenesis. Clinical Endocrinology, 62(1), 56-63. <ahref="http://dx.doi.org/10.1111/j.1365-2265.2004.02173.x">[More Information]</a>

Skilton, M., Evans, N., Griffiths, K., Harmer, J., Celermajer, D.(2005). Aortic wall thickness in newborns with intrauterinegrowth restriction. The Lancet, 365(9469), 1484-1486. <ahref="http://dx.doi.org/10.1016/S0140-6736(05)66419-7">[More Information]</a>

Joshua, A., Celermajer, D., Stockler, M. (2005). Beauty is in theeye of the examiner: reaching agreement about physical signsand their value. Internal Medicine Journal, 35(3), 178-187. <ahref="http://dx.doi.org/10.1111/j.1445-5994.2004.00795.x">[More Information]</a>

Celermajer, D. (2005). Brachial artery FMD with 5-minutedistal cuff occlusion--a useful pathophysiological test after all!.Journal of Applied Physiology, 99(4), 1619. <ahref="http://dx.doi.org/10.1152/japplphysiol.00726.2005">[More Information]</a>

Celermajer, D. (2005). Cardiovascular implications ofChildhood Obesity. World Congress of Paediatric Cardiologyand Cardiac Surgery.

Maple-Brown, L., O'Rourke, M., Piers, L., Celermajer, D.,O'Dea, K. (2005). Central obesity is associated with reducedperipheral wave reflection in Indigenous Australiansirrespective of diabetes status. Journal of Hypertension, 23(7),1403-1407. <ahref="http://dx.doi.org/10.1097/01.hjh.0000173524.80802.5a">[More Information]</a>

Chow, C., Amos, D., Celermajer, D. (2005). Cerebrovascularevents in young adults after surgical repair of tetralogy ofFallot. Cardiology in the Young, 15(2), 130-132. <ahref="http://dx.doi.org/10.1017/S1047951105000296">[MoreInformation]</a>

Sieveking, D., Woo, K., Fung, K., Lundman, P., Nakhla, S.,Celermajer, D. (2005). Chinese herbs Danshen and Gegenmodulate key early atherogenic events in vitro. InternationalJournal of Cardiology, 105(1), 40-45. <ahref="http://dx.doi.org/10.1016/j.ijcard.2004.10.052">[MoreInformation]</a>

Nicholls, S., Celermajer, D., Rye, K., Barter, P., Griffiths, K.,Cutri, B., Harmer, J., Lundman, P. (2005). Consumption ofsaturated fat impairs endothelial function and theantiinflammatory properties of high-density lipoproteins.Circulation, 112(17), U43.

Thanyasiri, P., Celermajer, D., Adams, M. (2005). Endothelialdysfunction occurs in peripheral circulation in patients withacute and stable coronary artery disease. American Journal of

Physiology - Heart and Circulatory Physiology, 289(2), H513-H517. <ahref="http://dx.doi.org/10.1152/ajpheart.01086.2004">[MoreInformation]</a>

Celermajer, D. (2005). Endothelin and pulmonary hypertension.Australian Pulmonary Hypertension Experts Meeting.

Skilton, M., Lai, N., Griffiths, K., Molyneaux, L., Yue, D.,Sullivan, D., Celermajer, D. (2005). Meal-related increases invascular reactivity are impaired in older and diabetic adults:insights into roles of aging and insulin in vascular flow.American Journal of Physiology - Heart and CirculatoryPhysiology, 288(3), H1404-H1410. <ahref="http://dx.doi.org/10.1152/ajpheart.00484.2004">[MoreInformation]</a>

Lundman, P., Keech, A., Griffiths, K., Pillai, A., Celermajer, D.(2005). New carotid plaque formation is very common in adultpatients with Type 2 diabetes mellitus. Diabetic Medicine,22(3), 355-356. <a href="http://dx.doi.org/10.1111/j.1464-5491.2005.01411.x">[More Information]</a>

Skilton, M., Nakhla, S., Sieveking, D., Caterson, I., Celermajer,D. (2005). Pathophysiological levels of the obesity relatedpeptides resistin and ghrelin increase adhesion moleculeexpression on human vascular endothelial cells. Clinical andExperimental Pharmacology and Physiology, 32(10), 839-844.<a href="http://dx.doi.org/10.1111/j.1440-1681.2005.04274.x">[More Information]</a>

Celermajer, D. (2005). Prevention of long-term cardiovasculardisease in children. World Congress of Paediatric Cardiologyand Cardiac Surgery.

Celermajer, D. (2005). Primary and a half prevention: can weidentify asymptomatic subjects with high vascular risk? (Editorial Comment). Journal of the American College ofCardiology, 45(12), 1994-1996. <ahref="http://dx.doi.org/10.1016/j.jacc.2005.03.019">[MoreInformation]</a>

Sheil, M., Luxford, C., Davies, M., Peat, J., Nunn, G.,Celermajer, D. (2005). Protein oxidation injury occurs duringpediatric cardiopulmonary bypass. Journal of Thoracic andCardiovascular Surgery, 130(4), 1054-1061. <ahref="http://dx.doi.org/10.1016/j.jtcvs.2005.03.048">[MoreInformation]</a>

Celermajer, D. (2005). Putting patients first. 2nd ScientificSymposium, Dual ERA.

Celermajer, D. (2005). Quality of Life in PulmonaryHypertension. 4th Scientific Symposium on Endothelin-RelatedDiseases.

Kilian, J., Nakhla, S., Griffith, K., Harmer, J., Skilton, M.,Celermajer, D. (2005). Reperfusion injury in the human forearmis mild and not attenuated by short-term ischaemicpreconditioning. Clinical and Experimental Pharmacology andPhysiology, 32(01-Feb), 86-90. <ahref="http://dx.doi.org/10.1111/j.1440-1681.2005.04163.x">[More Information]</a>

Lattimore, J., Wilcox, I., Nakhla, S., Langenfeld, M., Jessup,W., Celermajer, D. (2005). Repetitive hypoxia increases lipidloading in human macrophages-a potentially atherogenic effect.Atherosclerosis, 179(2), 255-259. <ahref="http://dx.doi.org/10.1016/j.atherosclerosis.2004.11.010">[More Information]</a>

Kilian, J., Celermajer, D., Adams, M. (2005). Safety ofcoronary angioplasty to chronic total occlusions. InternationalJournal of Cardiology, 103(3), 256-258. <ahref="http://dx.doi.org/10.1016/j.ijcard.2004.07.025">[MoreInformation]</a>

Celermajer, D. (2005). Selective endothelin-A antagonism isnot superior to dual endothelin antagonism in the treatment ofpulmonary artery hypertension. American Thoracic Societyannual scientific sessions.

Chow, C., Mou, D., Patel, A., Celermajer, D. (2005). The roleof the 12-lead ECG as a screening test for cardiac source ofembolus. Heart, Lung, and Circulation, 14(4), 242-244. <ahref="http://dx.doi.org/10.1016/j.hlc.2005.06.010">[MoreInformation]</a>

Keech, A., Grieve, S., Patel, A., Griffiths, K., Skilton, M.,Watts, G., Marwick, T., Groshens, M., Celermajer, D. (2005).Urinary albumin levels in the normal range determine arterialwall thickness in adults with Type 2 diabetes: a FIELDsubstudy. Diabetic Medicine, 22(11), 1558-1565. <ahref="http://dx.doi.org/10.1111/j.1464-5491.2005.01688.x">[More Information]</a>

Kwok, T., Chook, P., Tam, L., Qiao, M., Woo, J., Celermajer,D., Woo, K. (2005). Vascular dysfunction in Chinesevegetarians: an apparent paradox? Journal of the AmericanCollege of Cardiology, 46(10), 1957-1958. <ahref="http://dx.doi.org/10.1016/j.jacc.2005.07.054">[MoreInformation]</a>

2004Kerridge, I., Stewart, G., Raper, M., Celermajer, D., Willcock,S. (2004). "The Future of Medicine" - What is wrong withmedicine today? and Where is the future of medicine?.

Celermajer, D. (2004). Androgens and atherosclerosis.International Society for Heart Research Scientific Sessions.

Celermajer, D. (2004). Androgens and the heart. EndocrineSociety Of Australia.

Celermajer, D. (2004). Childhood obesity and atherosclerosis –keynote Lecture. South African Heart Association.

Celermajer, D. (2004). Cholesterol lowering andatherosclerosis. International Clinical Trials Symposium.

Celermajer, D. (2004). Closing holes in the heartpercutaneously – state of the art. SAARC annual scientificsessions.

Thomas, G., Chook, P., Qiao, M., Huang, X., Leong, H.,Celermajer, D., Woo, K. (2004). Deleterious Impact Of "HighNormal" Glucose Levels And Other Metabolic SyndromeComponents On Arterial Endothelial Function And Intima-Media Thickness In Apparently Healthy Chinese Subjects: TheCATHAY Study. Arteriosclerosis, Thrombosis, and VascularBiology, 24(4), 739-743. <ahref="http://dx.doi.org/10.1161/01.ATV.0000118015.26978.07">[More Information]</a>

Heather, A., McGrath, K., Sader, M., Nakhla, S., Jessup, W.,Handelsman, D., Celermajer, D. (2004). DihydrotestosteronePromotes Vascular Cell Adhesion Molecule-1 Expression InMale Human Endothelial Cells Via A Nuclear Factor-κB-Dependent Pathway. Endocrinology, 145(4), 1889-1897. <ahref="http://dx.doi.org/10.1210/en.2003-0789">[MoreInformation]</a>

Celermajer, D. (2004). Dual cholesterol inhibition. SouthAfrican Heart Association.

Woo, K., Chook, P., Yu, C., Sung, R., Qiao, M., Leung, S.,Lam, C., Metreweli, C., Celermajer, D. (2004). Effects Of DietAnd Exercise On Obesity-Related Vascular Dysfunction InChildren. Circulation, 109(16), 1981-1986. <ahref="http://dx.doi.org/10.1161/01.CIR.0000126599.47470.BE">[More Information]</a>

Celermajer, D. (2004). Fetal origins of atherosclerosis. South

African Heart Association.

Woodman, R., Celermajer, D., Thompson, P., Hung, J. (2004).Folic Acid Does Not Improve Endothelial Function In HealthyHyperhomocysteinaemic Subjects. Clinical Science, 106(4),353-358. <ahref="http://dx.doi.org/10.1042/CS20030296">[MoreInformation]</a>

Celermajer, D. (2004). Following the sick aorta. CardiacSociety of Australia and New Zealand.

Ng, M., Celermajer, D. (2004). Glucocorticoid treatment andcardiovascular disease. Heart, 90(Aug.), 829-830. <ahref="http://dx.doi.org/10.1136/hrt.2003.031492">[MoreInformation]</a>

Celermajer, D. (2004). Interventions for adults congenital heartdisease. South African Heart Association.

Skilton, M., Ho, L., Gosby, A., Caterson, I., Celermajer, D.(2004). Maternal Undernutrition And Early Postnatal DietAffect Aortic Structure And Composition In Rats. Journal ofthe American College of Cardiology, 43 Abstracts(5), 517A-517A.

Celermajer, D., Greaves, K., Puranik, R., O'Leary, J. (2004).Myocardial Tissue Velocities In The Normal Left And RightVentricles: Relationships And Predictors. Heart, Lung, andCirculation, 13(4), 367-373.

Woo, K., Chook, P., Yu, C., Sung, R., Leung, S., Qiao, M.,Lam, C., Metreweli, C., Celermajer, D. (2004). Overweight InChildren Is Associated With Arterial Endothelial DysfunctionAnd Intima-Media Thickening. International Journal ofObesity, 28(7), 852-857. <ahref="http://dx.doi.org/10.1038/sj.ijo.0802539">[MoreInformation]</a>

Celermajer, D. (2004). The endothelium for cardiologists.Cardiac Society of Australia and New Zealand.

Sullivan, D., Celermajer, D., Le Couteur, D., Lam, C. (2004).The Vascular Implications Of Postprandial LipoproteinMetabolism. Clinical Biochemist Reviews, 25(1), 19-30.

Celermajer, D. (2004). Vascular biology and obesity – KeynoteLecture. 6th Hong Kong East Meets West Symposium.

2003Celermajer, D. (2003). ACE-inhibitors and long-term outcomes.Satellite to the American Heart Association.

Celermajer, D. (2003). Ageing and cardiovascular disease. LifeExtension Symposium.

Ng, M., Quinn, C., McCrohon, J., Nakhla, S., Jessup, W.,Handelsman, D., Celermajer, D., Heather, A. (2003).Androgens Up-Regulate Atherosclerosis-Related Genes inMacrophages From Males But Not Females: Molecular InsightsInto Gender Differences in Atherosclerosis. Journal of theAmerican College of Cardiology, 42(7), 1306-1313. <ahref="http://dx.doi.org/10.1016/j.jacc.2003.07.002">[MoreInformation]</a>

Greaves, K., Mou, D., Patel, A., Celermajer, D. (2003). Clinicalcriteria and the appropriate use of transthoracicechocardiography for the exclusion of infective endocarditis.Heart, 89(3), 273-275.

Celermajer, D. (2003). Clinical Trials: Evidence andUnanswered Questions Hypertension. CerebrovascularDiseases, 16(Suppl. 3), 18-24. <ahref="http://dx.doi.org/10.1159/000070273">[MoreInformation]</a>

Celermajer, D., Deanfield, J. (2003). Congenital heart disease in

adolescents and adults. (CHD in Adolescence). In AndersonRH, Tynan M, Rigby M (Eds.), Paediatric Cardiology, (pp.1893-1925). London: Churchill Livingstone.

Sheil, M., Cartmill, T., Nunn, G., Sholler, G., Raitakari, O.,Celermajer, D. (2003). Contrast echocardiography: potential forthe in-vivo study of pediatric myocardial preservation. Annalsof Thoracic Surgery, 75(5), 1542-1549. <ahref="http://dx.doi.org/10.1016/S0003-4975(02)04888-9">[More Information]</a>

Ng, M., Nakhla, S., Baoutina, A., Jessup, W., Handelsman, D.,Celermajer, D. (2003). Dehydroepiandrosterone, an adrenalandrogen, increases human foam cell formation. Journal of theAmerican College of Cardiology, 42(11), 1967-1974. <ahref="http://dx.doi.org/10.1016/j.jacc.2003.07.024">[MoreInformation]</a>

Celermajer, D., Deanfield, J. (2003). Diseases of the tricuspidvalve. In Anderson RH, Tynan M, Rigby M (Eds.), PaediatricCardiology, (pp. 1111-1133). London: Churchill Livingstone.

Liu, P., Wishart, S., Celermajer, D., Jimenez, M., Di Pierro, I.,Conway, A., Handelsman, D. (2003). Do reproductivehormones modify insulin sensitivity and metabolism in oldermen? A randomised, placebo-controlled clinical trial ofrecombinant human chorionic gonadotropin. European Journalof Endocrinology, 148(1), 55-56. <ahref="http://dx.doi.org/10.1530/eje.0.1480055">[MoreInformation]</a>

Griffiths, K., Sader, M., Skilton, M., Harmer, J., Celermajer, D.(2003). Effects of Raloxifene on endothelium-dependentdilation, lipoproteins, and markers of vascular function inpostmenopausal women with coronary artery disease. Journalof the American College of Cardiology, 42(4), 698-704. <ahref="http://dx.doi.org/10.1016/S0735-1097(03)00776-9">[More Information]</a>

Celermajer, D. (2003). Heart disease in Australia. Royal Societyof New South Wales, Melbourne: University of Melbourne.

Celermajer, D. (2003). Molecular effects of androgens on thevasculature. Cardiology Grand Rounds, Oxford: OxfordUniversity Press.

Langenfeld, M., Simmons, L., McCrohon, J., Raitakari, O.,Lattimore, J., Hennessy, A., Celermajer, D. (2003). NitricOxide does not Mediate the Vasodilation of Early HumanPregnancy. Heart, Lung, and Circulation, 12(3), 142-148. <ahref="http://dx.doi.org/10.1046/j.1444-2892.2003.00206.x">[More Information]</a>

Celermajer, D. (2003). Non-invasive detection ofatherosclerosis. Eleventh Annual Spring Desert CardiovascularUpdate.

Lattimore, J., Celermajer, D., Wilcox, I. (2003). Obstructivesleep apnea and cardiovascular disease. Journal of theAmerican College of Cardiology, 41(9), 1429-1437. <ahref="http://dx.doi.org/10.1016/S0735-1097(03)00184-0">[More Information]</a>

Sader, M., Griffiths, K., Skilton, M., Wishart, S., Handelsman,D., Celermajer, D. (2003). Physiological testosteronereplacement and arterial endothelial function in men. ClinicalEndocrinology, 59(1), 62-67. <ahref="http://dx.doi.org/10.1046/j.1365-2265.2003.01796.x">[More Information]</a>

Greaves, K., Bye, P., Parker, G., Celermajer, D. (2003).Prevalence of haemoptysis in adults with pulmonary atresia and ventricular septal defect, and the role of mammary artery collateral vessels. Heart, 89(8),937-938.

Lau, A., Leichtweis, S., Hume, P., Mashima, R., Hou, J.,

Chaufour, X., Wilkinson, B., Hunt, N., Celermajer, D., Stocker,R. (2003). Probucol promotes functional reedothelialization inballoon-injured rabbit aortas. Circulation, 107(15), 2031-2036.<ahref="http://dx.doi.org/10.1161/01.CIR.0000062682.40051.43">[More Information]</a>

Celermajer, D. (2003). Sex and the heart. 24th PanhellenicCardiological Conference.

Celermajer, D. (2003). Size of plaque doesn't matter. EleventhAnnual Spring Desert Cardiovascular Update.

Puranik, R., Celermajer, D. (2003). Smoking and EndothelialFunction. Progress In Cardiovascular Diseases, 45(6), 443-458. <ahref="http://dx.doi.org/10.1053/pcad.2003.YPCAD13">[MoreInformation]</a>

Celermajer, D. (2003). Statins, skin, and the search for a test ofendothelial function. Journal of the American College ofCardiology, 42(1), 78-80. <ahref="http://dx.doi.org/10.1016/S0735-1097(03)00508-4">[More Information]</a>

2002Celermajer, D. (2002). Angiotensin II and atherogenesis.Canadian Vascular Biology Working Group.

Kilian, J., Keech, A., Adams, M., Celermajer, D. (2002).Coronary collateralization: determinants of adequate distalvessel filling after arterial occlusion. Coronary Artery Disease,13(3), 155-159. <a href="http://dx.doi.org/10.1097/00019501-200205000-00004">[More Information]</a>

Sader, M., Celermajer, D. (2002). Endothelial function,vascular reactivity and gender differences in the cardiovascularsystem. Cardiovascular Research, 53, 597-604. <ahref="http://dx.doi.org/10.1016/S0008-6363(01)00473-4">[More Information]</a>

Freedman, B., Brieger, D., Celermajer, D., Chalmers, J., Tofler,G., Campbell, T., Feneley, M., Marwick, T., Muller, D.,Tonkin, A. (2002). Global cardiology comes to Australia: 14thWorld Congress of Cardiology, Sydney, 5-9 May 2002.Medical Journal of Australia, , 473-475. <ahref="http://dx.doi.org/10.5694/j.1326-5377.2002.tb04913.x">[More Information]</a>

Corretti, M., Anderson, T., Benjamin, E., Celermajer, D.,Charbonneau, F., Creager, M., Deanfield, J., Drexler, H.,Gerhard-Herman, M., Herrington, D., et al (2002). Guidelinesfor the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of theInternational brachial Artery Reactivity Task Force. Journal ofthe American College of Cardiology, 39(2), 257-265. <ahref="http://dx.doi.org/10.1016/S0735-1097(01)01746-6">[More Information]</a>

Celermajer, D. (2002). International Cardiovascular ProfessorProgram – Pfizer Canada – lecture tour of Vancouver. Lecturetour of Vancouver.

Woo, K., Chook, P., Chan, L., Cheung, A., Fung, W., Qiao, M.,Lolin, Y., Thomas, G., Sanderson, J., Metreweli, C.,Celermajer, D. (2002). Long-term improvement inhomocysteine levels and arterial endothelial function after 1-year folic acid supplmentation. The American Journal ofMedicine, 112(7), 535-539. <ahref="http://dx.doi.org/10.1016/S0002-9343(02)01075-6">[More Information]</a>

Sader, M., Miller, L., Caine, D., McCredie, R., Corr, M.,Robertson, M., Watson, J., Celermajer, D. (2002).Neuropsychological and psychiatric outcomes following

coronary surgery or angioplasty: a comparative study. Heart,Lung, and Circulation, 11(2), 95-101. <ahref="http://dx.doi.org/10.1046/j.1444-2892.2002.00127.x">[More Information]</a>

Heather, A., Nakhla, S., McGrath, K., Martell, S., Yue, D.,Celermajer, D., Jessup, W. (2002). Nitroglycerin upregulatesmatrix metalloproteinase expression by human macrophages.Journal of the American College of Cardiology, 39(12), 1943-1950. <a href="http://dx.doi.org/10.1016/S0735-1097(02)01907-1">[More Information]</a>

Celermajer, D. (2002). Non-invasive detection ofpresymptomatic atherosclerosis. Hong Kong College ofCardiology Annual Scientific Sessions.

Wilson, S., Best, P., Edwards, W., Holmes, D., Carlson, P.,Celermajer, D., Lermin, A. (2002). Nuclear factor-kappaBimmunoreactivity is present in human coronary plaque andenhanced in patients with unstable angina pectoris.Atherosclerosis, 160(1), 147-153. <ahref="http://dx.doi.org/10.1016/S0021-9150(01)00546-9">[More Information]</a>

Dzau, V., Bernstein, K., Celermajer, D., Cohen, J., Dahlof, B.,Deanfield, J., Diez, J., Drexler, H., Ferrari, R., van Gilst, W., etal (2002). Pathophysiologic and therapeutic importance oftissue ACE. Cardiovascular Drugs and Therapy, 16(2), 149-160. <ahref="http://dx.doi.org/10.1023/A:1015709617405">[MoreInformation]</a>

Ng, M., Liu, P., Williams, A., Nakhla, S., Ly, L., Handelsman,D., Celermajer, D. (2002). Prospective study of effect ofandrogens on serum inflammatory markers in men.Arteriosclerosis, Thrombosis, and Vascular Biology, 22(7),1136-1141. <ahref="http://dx.doi.org/10.1161/01.ATV.0000022167.80130.A6">[More Information]</a>

Celermajer, D. (2002). Size (of plaque) doesn't matter - the newbiology of atherosclerosis. South African Cardiac Society.

Celermajer, D. (2002). Size of plaque and atherosclerosis risk.Hong Kong College of Cardiology Annual General Meeting.

Celermajer, D., Greaves, K. (2002). Survivors of coarctationrepair: fixed but not cured. Heart, 88, 113-114. <ahref="http://dx.doi.org/10.1136/heart.88.2.113">[MoreInformation]</a>

Celermajer, D. (2002). Understanding the pathophysiology ofthe arterial wall: which method should we choose? EuropeanHeart Journal, 4(September), F24-F28.

Celermajer, D. (2002). Unresolved questions in hypertension.European Stroke Association Annual Scientific Sessions.

2001Ly, L., Zhuang, T., Celermajer, D., Handelsman, D., Jimenez,M., Conway, A. (2001). A double-blind, placebo-controlled,randomised clinical trial of transdermal dihydrotestosterone gelon muscular strength, mobility, and quality of life in older menwith partial androgen deficiency. The Journal of ClinicalEndocrinology and Metabolism, 86, 4078-4088. <ahref="http://dx.doi.org/10.1210/jc.86.9.4078">[MoreInformation]</a>

Sader, M., Griffiths, K., Handelsman, D., Celermajer, D.,McCredie, R. (2001). Androgenic anabolic steroids and arterialstructure and function in male body builders. Journal of theAmerican College of Cardiology, 37, 224-230.

Celermajer, D. (2001). Angiotensin and Vascular Biology.Taiwanese Heart Association Symposium.

Celermajer, D. (2001). Brachial artery ultrasound andatherosclerosis. Australasian Society for Ultrasound inMedicine.

Premawardhana, U., Adams, M., Yue, D., Celermajer, D.,Birrell, A. (2001). Cardiovascular structure and function inbaboons with Type 1 diabetes - a transvenous ultrasound study.Journal of Diabetes and Its Complications, 15, 174-180.

Langenfeld, M., Nakhla, S., Death, A., Jessup, W., Celermajer,D. (2001). Endothelin-1 and oxidized low density lipoprotein,but neither alone, increase human monocyte adhesion toendothelial cells. Clinical Science, 101, 731-738.

Heather, A., Jessup, W., Celermajer, D., Langdenfeld, M.,Nakhla, S. (2001). Endothelin-1 plus oxidized low-densitylipoprotein, but neither alone, increase human monocyteadhesion to endothelial cells. Clinical Science, 101, 731-738.

Celermajer, D. (2001). Evidence-based medicine: how good isthe evidence? Medical Journal of Australia, 174, 293-295.

Celermajer, D. (2001). Impact of New Diagnostic andIntervention Options on Prognosis in Coronary Disease.International Congress of Life and Health Assurance.

Seale, J., Celermajer, D., Raitakari, O. (2001). Impairedvascular responses to nitroglycerin in subjects with coronaryatherosclerosis. American Journal of Cardiology, 87, 217-219.

Celermajer, D., Jarvisalo, M., Jartti, L., Nanto-Salonen,, K.,Irjala, K., Ronnemaa, T., Hartiala, J., Raitakari, O. (2001).Increased aortic intime-media thickness: a marker of preclinicalatherosclerosis in high-risk children. Circulation, 104, 2943-2947.

Sader, M., Griffiths, K., Handelsman, D., Celermajer, D.,McCredie, R., Wishart, S. (2001). Oestradiol improves arterialendothelial function in health men receiving testosterone.Clinical Endocrinology, 54, 175-181. <ahref="http://dx.doi.org/10.1046/j.1365-2265.2001.01176.x">[More Information]</a>

Sader, M., McCredie, R., Griffiths, K., Wishart, S.,Handelsman, D., Celermajer, D. (2001). Oestradiol improvesarterial endothelial function in healthy men receivingtestosterone. Journal of the American College of Cardiology,54, 175-181.

Ng, M., Jessup, W., Celermajer, D. (2001). Sex-relateddifferences in the regulation of macrophage cholesterolmetabolism. Current Opinion in Lipidology, 12, 506-510.

Celermajer, D., Woo, J., Woo, K., Leung,, S., Chook, P., Liu,,B., Ip,, R., Ho, S., Chan, S., Feng, J. (2001). The Mediterraneanscore of dietary habits in Chinese populations in four differentgeographical areas. European Journal of Clinical Nutrition, 55,215-220.

Dzau, V., Bernstein, M., Celermajer, D. (2001). The Relevanceof tissue ACE: manifestations in mechanistic and endpoint data.American Journal of Cardiology, 88, 1-20.

Woo, K., Chook, P., Chan, W., So, W., Cockram, C.,Celermajer, D. (2001). Type I diabetes and arterial dysfunctionin asymptomatic Chinese adults. Diabetes Care, 24, 173.

2000Celermajer, D. (2000). ACE inhibition and atherogenesis.International tissue ACE symposium.

Premawardhana, U., Celermajer, D. (2000). Advances inechocardiography. Internal Medicine Journal, 30, 360-366.

McCrohon, J., Death, A., Nakhla, S., Jessup, W., Handelsman,D., Stanley, K., Celermajer, D. (2000). Androgen receptorexpression is greater in macrophages from male than from

female donors. Circulation, 101, 224-226. <ahref="http://dx.doi.org/10.1161/01.CIR.101.3.224">[MoreInformation]</a>

Celermajer, D. (2000). Benefits of Aggressive Lipid Lowering.Indonesia Atherosclerosis Society.

Raitakari, O., McCredie, R., Letters, J., Witting, P., Griffiths,K., Sullivan, D., Stocker, R., Celermajer, D. (2000). CoenzymeQ improves LDL resistance to ex vivo oxidation but does notenhance endothelial function in hypercholesterolemic youngadults. Free Radical Biology and Medicine, 28, 1100-1105.

McCrohon, J., Woo, K., Celermajer, D. (2000). Comparison ofendothelial function in Caucasian and Chinese women beforeand after the menopause. Maturitas, 35, 31-37.

Celermajer, D. (2000). Early Detection of Atherosclerosis.South African Heart Association.

Raitakari, O., Celermajer, D. (2000). Flow-mediated dilatation.British Journal of Clinical Pharmacology, 50, 397-404.

Rasko, J., Celermajer, D. (2000). Gene therapy for vasculardiseases. In RT Dean, D Kelly (Eds.), Atherosclerosis: GeneExpression, Cell Interactions, and Oxidation, (pp. 112-136).Oxford: Oxford University Press.

Celermajer, D. (2000). Inflammation in coronary disease. WHFCardiology Year 2000 Course.

Miller, O., Tang, S., Keech, A., Pigott, N., Beller, E.,Celermajer, D. (2000). Inhaled nitric oxide and prevention ofpulmonary hypertension after congenital heart surgery: arandomised double-blind study. The Lancet, 356(9240), 1464-1469. <a href="http://dx.doi.org/10.1016/S0140-6736(00)02869-5">[More Information]</a>

Hornung, T., Celermajer, D., Sholler, G., Miller, O. (2000). Isnitric oxide implicated in pulmonary arteriovenous fistulaformation? Pediatric Cardiology.

Graham, T., Bernardel, G., Mellen, B., Celermajer, D. (2000).Long term outcome in congenitally corrected transposition ofthe great arteries. Journal of the American College ofCardiology, 36(1), 255-261.

Celermajer, D. (2000). New techniques for detecting coronaryatherosclerosis. European Society of Cardiology.

Celermajer, D. (2000). Nitric Oxide and Atherosclerosis. HongKong College of Cardiology Annual Scientific Sessions.

Celermajer, D. (2000). Nitric Oxide and the arterialendothelium. Taiwan Cardiac Society.

Celermajer, D. (2000). Obesity and Vascular Disease. SouthAfrican Heart Association.

Raitakari, O., Adams, M., McCredie, R., Griffiths, K., Stocker,R., Celermajer, D. (2000). Oral vitamin C and endothelialfunction in smokers: acute improvement, but no sustainedbeneficial effect. Journal of the American College ofCardiology, 35, 1616-1621.

Raitakari, O., Adams, M., McCredie, R., Griffiths, K., Stocker,R., Celermajer, D. (2000). Oral vitamin C and endothelialfunction in smokers: short-term improvement, but no sustainedbeneficial effect. Journal of the American College ofCardiology, 35, 1616-1621.

Simons, L., Von Konigsmark, M., Simons, J., Celermajer, D.(2000). Phytoestrogens do not influence lipoprotein levels orendothelial function in healthy post-menopausal women.American Journal of Cardiology, 85, 1297-1301.

Raitakari, O., Lai, N., Griffiths, K., McCredie, R., Sullivan, D.,Celermajer, D. (2000). Preserved endothelial function andenhanced peripheral vasodilation in humans after a fatty meal.

Journal of the American College of Cardiology, 36, 417-422.

Lau, A., Witting, P., Chaufour, X., Celermajer, D., Pettersson,K., Stocker, R. (2000). Protective effects of probucol in twoanimal models of atherosclerosis. Redox Report, 5, 116-118.

Celermajer, D. (2000). Recent advances in atherosclerosis.Lebanese Heart Association.

Celermajer, D. (2000). Risk factors for Australian children.Medical Journal of Australia, 173, S11-12.

Millane, T., Bernard, E., Jaeggi, E., Uren, R., Cartmill, T.,Hawker, R., Homan-Giles, R., Celermajer, D. (2000). Role ofischemia and infarction in the late right ventricular dysfunctionfollowing atrial repair of transposition of the great arteries.Journal of the American College of Cardiology, 35, 1661-1668.

Celermajer, D. (2000). Sex Steroids and the Heart. SouthAfrican Heart Association.

Raitakari, O., Celermajer, D. (2000). Testing for endothelialdysfunction. Annals of Internal Medicine, 32, 293-304.

Celermajer, D. (2000). The effects of risk factors and race onendothelial function. International Atherosclerosis Society.

Celermajer, D. (2000). The Endothelium and Angiotensin.American Heart Association. High Blood Pressure Research,American Heart Association: American Heart Association.

Woo, K., Chook, P., Leong, H., Huang, X., Celermajer, D.(2000). The impact of heavy passive smoking on arterialendothelial function in modernized Chinese. Journal of theAmerican College of Cardiology, 36, 1228-1232. <ahref="http://dx.doi.org/10.1016/S0735-1097(00)00860-3">[More Information]</a>

Celermajer, D. (2000). The role of antioxidants inatherosclerosis. International Faculty on Endothelial Function.

Premawardhana, U., Hoskins, M., Celermajer, D. (2000).Transvenous ultrasound in baboons; a novel window to thecardiovascular system. Clinical Science, 99, 141-147.

Celermajer, D., Vita, J. (2000). Vascular dysfunction and itscontribution to atherogenesis. In RT Dean, D Kelly (Eds.),Atherosclerosis: Gene Expression, Cell Interactions, andOxidation, (pp. 88-111). Oxford: Oxford University Press.